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B3-induced myocarditis 412Baccharin 735 structure of 735Baccharinoids 743Baccharinol 736 structure of 736Bacchariolide A 716 structure of 716Bacchariolide B 717 structure of 717*Baccharis* species 706 acetylenic compounds of 706baccharis oxide from 706diterpene derivatives of 706essential oils from 706labdane derivatives of 706sesquiterpenes from 706*Baccharis anomala* D.C. 750 microsomal activation by 750*Baccharis artemisioides* D.C. 751*Baccharis articulata* 706, 708, 723, 743, 744, 750 articulin from 708as antidiabetic 706as decoctions 706as infusions 706bacchotricuneatin A from 708barticulidiol from 708β-caryophyllene from 723in treatment of rheumatism 744in ulcers 744inhibition of viral infectivity by 743neo-clerodane type 708nerolidol from 723use as raw material for preparation of phytotherapeutic drugs 750*Baccharis boliviensis* 711, 712, 730, 742 coumaric acids 730*ent*-clerodane derivatives from 711*ent*-clerodane furanoditerpenoid from 711labdane-type diterpenes from 712structure of 730trypanocidal effect of 742*Baccharis calliprinos* Grised 746*Baccharis calvescens* D.C. 731 *p*-hydroxyacetophenones from 731structure of 731*Baccharis cassinaefolia* 708 bacchotricuneatin A from 708*Baccharis conferta* 704, 740, 748 against *Escherichia coli* 740antibacterial activity against*Micrococcus luteus* 740 as laxative 705for stimulating urination 705in treatment of baldness 705in treatment of gastrointestinal illnesses 748in treatment of insect bites 705in treatment of stomach aches 704triterpenoid oleanoic acid methyl ester from 740*Baccharis cordifolia* 743, 745 macrocyclic trichothecenes from 743*Baccharis cordobensis* 722 cadinol from 722cubenol from 722essential oil from 722nerolidol from 722*Baccharis coridifolia* 705, 717, 719, 733, 751 as anti-inflammatory 705baccharinoids from 717extract of 733in toxic disease 751in treatment of horse\'s external parasites 705roridins from 717, 751schottenol glucoside 719to treat horse\'s distemper 705toxins from 751ursolic acid from 719uvaol from 719verrucarins 717*Baccharis crispa* 722, 723, 739, 743, 744, 745, 750 antibacterial activity against 739antifungal activity against 739essential oil from 722in treatment of liver diseases 744nerolidol from 722phytotherapeutic drugs from 750*Baccharis dracunculifolia* 723, 730 dracunculifosides A-J from 730*Baccharis floribunda* 706*Baccharis gaudichaudiana* 706, 734 as antidiabetic material 706as decoction 706as infusion 706in P-388 lymphocytic leukemia cells 734*Baccharis genistelloides* 706, 711, 720, 733, 739, 740, 743, 744, 746, 748, 749, 750 against HSV-1 and VSV 743against *Staphylococcus aureus* 739anti-inflammatory constituents from 746against *Candida albicans* 739against gram-positive bacteria 739antimicrobial activity of 740antimutagen constituents from 733apigenin from 733as anti-inflammatory material 750as antithermic 706cirsimaritin from 733diterpene lactone from 740effects on bile duct 750effects on bone marrow 750effects on cardiac function 750effects on liver 750effects on pancreas 750effects on serum lipids 750genkwanin from 733hispidulin from 733in anaemia 706in diabetes 706in diarrhoea 706in digestive disorders 706in indigestion 706in inflammation 706in intestinal worms 706in leprosy 706in liver disorders 706, 733, 749in malaria 706in rheumatism 733in sore throat 706in tonisilitis 706in ulcers 706in urinary disorder 706β-sitosterol from 720stigmasterol from 720structure of 739, 740structure-activity relationship of 733use in liver diseases 749use in wounds 744*Baccharis* genus 707, 733, 738 antibacterial activity of 738antifungal activity of 738constituents of 707, 733diterpenoids from 733*epi*-methyltrineracetal from 707flavonoids from 733methyltrineracetal from 707*neo*-clerodane type diterpene 707secondary metabolites from 738*Baccharis glutinosa* 704, 739 antimicrobial activity of 739as contraceptive 704for digestive disorders 704for gynecological disorders 704for skin diseases 704in treatment of infectious diseases 739in weight reduction 704to clean wounds 704to treat scalp diseases 704*Baccharis grisebachii* 705, 730, 733, 739, 745 coumaric acids from 7303-(3,3-dimethylallyl)-*p*-coumaric acid from 730extract of 733for decoctions 705for poultices 705for wound healing 705inhibitory activity of 745spectrum of action of 739*Baccharis halimifolia* L. 718 baccharis oxide from 718*Baccharis heterophylla* *7* 18 oleanolic acid from 718*Baccharis incarum* 709, 744 bincatriol from 709*neo*-clerodane diterpenoid from 709*Baccharis intermixta* Gardn. 713*Baccharis* L. 704 biological activities of 704traditional uses of 704*Baccharis latifolia* 721, 731 oil 721*p*-hydroxyacetophenones from 731structure of 731*Baccharis macraei* 7 10 clerodane derivatives of 710hardwickiic acid from 710hautriwaic acid from 710*Baccharis magellamica* (Lam.) from 731 *p*-hydroxyacetophenones from 731propiophenone derivative 731structure of 731*Baccharis medullosa* 712, 744 as anti-inflammatory material 744*Baccharis megapotamica* 717, 736, 751 activity against P-388 leukemia 736against human carcinoma 736as cytotoxic agents 717baccharin from 736baccharinoids from 717baccharinol from 736bioassay-guided fractionation of 736extract of 736isobaccharin from 736isobaccharinol from 736roridins from 717toxins from 751verrucarins from 717*Baccharis multiflora* 705, 713 against catarrhs 705as infusion 705*ent*-kaurenic acid from 713*ent*-kaurenol from 713for urinary problems 705kaurane-type diterpenoids from 713*Baccharis myriocephala* D.C. 750*Baccharis myrsinites* 709, 718, 729 clerodane diterpenoid from 709coumaric acid from 729maniladiol from 718oleanolic acid from 718structure elucidation of 709*Baccharis myrtilloides* 723 germacrane D from 723*Baccharis notosergilla* 705, 739, 740, 742, 743 against gram-positive organisms 740against *Trypanosoma cruzi* 742antibacterial activity of 739, 740antifungal activity of 739as digestive agent 705as diuretic 705essential oil of 740in folk medicine 705Baccharis oxide 717 structure of 717*Baccharis oxydonta* 711, 728 *ent*-labdane diterpenes from 711pinobanksin from 728pinocembrin from 728*Baccharis paniculata* 710, 712, 731, 740 acetylenic lactones from 731against phytopathogenic fungi 740for antifungal activity against human pathogens from 7403-methyl ether flavone 740*neo*-clerodane diterpenoids from 710prenylated coumarin from 740*Baccharis pingraea* *7* 12 furolabdane diterpenoids from 712furolabda-6,8-dien-17-oic acid from 712furolabda-7-en-17-oic acid from 712*Baccharis pteroniodes* 711 *ent*-clerodane diterpenoids from 711*neo*-clerodane diterpenoids from 711*Baccharis ramoisissima* 713 *ent*-kaurenic acid from 713*ent*-kaurenol from 713*Baccharis rhetinoides* 746 anti-inflammatory flavonoids from 746homoeriodictyol from 746*Baccharis rubricaulis* 706 for treating mucous ailments 706*Baccharis rufescens* 723, 744 as anti-inflammatory 744limonene from 723nerolidol from 723*Baccharis salicifolia* 705, 707, 718, 721, 722, 731, 732 baccharis oxide from 718*ent*-clerodane derivatives from 707essential oil from 722for diarrhoea 705for dysentery 705for inflammation 705germacrane D from 722oils from 721prenyl derivatives from 731structure of 732*Baccharis salicina* 715 bacchariolides from 715chemical analysis of 715guaianolides from 715*Baccharis santelicis* 709*Baccharis sarothroides* 705, 710, 733 centaureidin from 733cytotoxic flavonols from 7333,4′-dimethoxy-3′,5,7-trihydroxyflavone from 733hautriwaic acid from 7102β-hydroxyhautriwaic acid from 710identification of 733inhibitory activity against human carcinoma 733*Baccharis scoparia* 711, 712 labdane aldehyde from 712structure of 712*Baccharis serraefolia* 705, 720, 739, 748 against *Candida albicans* 739against *Staphylococcus aureus* 739against gram-positive organisms 739mechanism of action of 748phytol from 720β-sitosterol from 720spasmolytic action of 748to treat diarrhoea 705use in gastrointestinal illnesses 705*Baccharis spartioides* 715 spartidienedione from 715*Baccharis spartioides* 723 essential oil of 723*Baccharis* species 707, 711, 750 for preparation of phytotherapeutic drugs 750parts of 707toxicological evaluation of 750used as raw material 750*Baccharis sphaerocephala* 715 amorphane sesquiterpene γ-lactol from 715*O*-methylbaccharocephol from 715*Baccharis* spp. 737, 740, 741 antineoplastic activity of 737apigenin from 740assay-guided fractionation of 737genkwanin from 740pentacyclic triterpenoids from 737structure of 741*Baccharis sternbergiana* 712*Baccharis tola* 714, 725 *ent*-4α-hydroxy-19-norbeyer-15-ene from 714*ent*-beyer-15-en-17, 19-ol from 714*ent*-beyerane-type diterpenoids from 714flavone from 725*Baccharis tricuneata* 706, 708, 719 α-amyrin acetate from 719bacchotricuneatin A from 708for diabetes from 706for skin infections 706friedelin from 719β-sitosterol from 719ursolic acid from 719*Baccharis trimera* 706 as antithermic agent 706for digestive disorders 706for liver disorders 706use in anaemia 706use in diabetes 706use in diarrhoea 706use in indigestion 706use in inflammation 706use in intestinal worms 706use in leprosy 706use in malaria 706use in sore throat 706use in tonsilitis 706use in ulcers 706use in urinary diseases 706*Baccharis trinervis* 705, 725, 743 against human immunodeficiency virus 743antiviral activity of 743apigenin from 725flavones from 725flavonol from 725for gastrointestinal disorders 705in dizziness 705in MT-2 infected cells 743in treatment of edema 705in treatment of high fever 705in treatment of muscle cramps 705in treatment of sores 705in treatment of typhoid fever 705inhibition of HSV-1743pectolinaringenin (5,7-dihydroxy-6,4′-dimethoxyflavone) from 725pedunletin (5,4′-dihydroxy-3,6,7-trimethoxyflavone) from 725salvigenin (5-hydroxy-6,7,4′-trimethoxyflavone) from 725*Baccharis triptera* Mart 749 in gastrointestinal disorders 749in gastrointestinal hyperactivity 749*Baccharis tucumanensis* 705, 733, 744 anti-inflammatory action of 745as abortive 705extract of 733in carrageenan foot edema test 745role in croton oil induced mouse ear edema test 745*Baccharis uncinella* D.C. 723 essential oil from 723*Baccharis vaccinoides* 705, 710, 739 against *Candida albicans* 739against *Staphylococcus aureus* 739antimicrobial activity *in vitro* 739for gastrointestinal disorders 705hautriwaic acid from 7102β-hydroxyhautriwaic acid from 710*Baccharis varians* 728, 729 3-acetoxyflavanones from 728Bacchotricuneatin A 709 structure of 709*Bacillus pumilus* 693*Bacillus subtilis* 693, 738 antifungal activity against 738Backebergine 563 from genus *Hernandia* 563from *Hernandia sonora* 563Bacteria 526Bacterial alkylresorcinols 166, 170 experiments with 170in lecithin black lipid membranc 166Bacterial effects 152 of *Streptococcus mutans* 152Bacterial hydrolysis 305 of sugar 305Bacterial infections 408Bacterial lipopolysaccharides 3-deoxy-D-manno-2-octulosonate 8-phosphate (KDO 8-P) 429 biosynthesis of 429(2*S*,2′*S*)-Bacterioruberin 517 structure of 517Bacterioruberin 523 as cell membrane stabilisers 523Baicalein 55, 69--72, 288 anti-inflammatory actions of 72as anti-allergic 71, 72from *Scutellaria baicalensis* 55, 69from *Scutellariae radix* 70inhibitory action of 70mechanisms of 70structure of 288BALB/c mice 592 epidermal cell culture of 592*Ballota nigra* 268 flavonoids from 268Banwell\'s *de novo* synthesis 461 of Neu5Ac 461Barticulidiol 709 structure of 709Basidiomycetous fungus 403 in folk medicine 403mode of antiviral activity of 403Bastaxanthin C 526, 527 structure of 526, 527Bastaxanthins 526Behavioral dysfunction 368 effect of serotonergic neurotransmission on 368*Bemisia tabaci* 332Benzenoid compounds 594, 562, 567 from genus *Hernandia* 562, 566, 567, 594Benzofuran-2-carboxylic acids 221Benzophenones 622 from *Hypericum* 622Benzoyl compounds 236 structure of 2361-Benzyl-3-methylnaphthalene 217 formation of 217from phenylacetone 217Benzyloxy(benzyloxycarbonyl)methyl)-trimethylphosphonium 441Beta-cells 370 activity of tryptophan hydroxylase (TPH) in 370Betulinaldehyde-3 β-yl-caffeate 646 from *Celastrus stephanotifolius* 6462D NMR of 646stereochemistry of 646NOESY spectrum of 646structure of 64613,1 18-Biapigenin 618 structure of 618Bicyclic cannabinoids 196, 197, 198 group of cannabinoid receptor ligands 197Bicyclic *C*-glycoside 470 cleavage of 470Biflavonoids 207 antinocicieptive effect of 207Binatriol 710 structure of 710Binding affinity 494 of 1α,25(OH)~2~D analogue 494of 1α,25(OH)~2~D~2~ 494of 1α,25(OH)~2~D~3~ 494of 1α,25(OH)~2~D~4~ 494of 1α,25(OH)~2~D~7~ 494of 24-*epi*-1α,25(OH)~2~D~2~ 494Binding assay 494 of calf-thymus vitamin D receptor 494Binding bioactivity 813 of \[Tyr)Me)~2~-Phe\] peptides 813of d-Tyr(Me)~2~-d-Phe-G-V-V-NH~2~ 813of d-Tyr(Me)~2~-d-Phe-NH~2~ 813of d-Tyr(Me)~2~-Phe-G-V-V-NH~2~ 813of d-Tyr(Me)~2~-Phe-NH~2~ 813of Tyr(Me)~2~-d-Phc-G-V-V-NH~2~ 813of Tyr(Me)~2~-d-Phe-NH~2~ 813of Tyr(Me)~2~-Phe-G-V-V-NH~2~ 813of Tyr(Me)~2~-Phe-NH~2~ 813Bioactive 3-deoxy-ulosonic acids 419 recent advances in 419Bioactive constituents 559 of genus *Hernandia* 559Bioactive triterpenes 635 from celastraceae 635Bioactivity 233, 516, 520 of carotenoids 516, 520of labiatae flavonoids 233Bioassay-directed fractionation 157, 591 of *Ozoroa insignis* 157use of chromatographic techniques in 591Bioassays 801Biochemical assays 226 activity of natural polyphenols in 226Biogenetic precursors 622 of xanthones 622Biological activity 4, 26, 172, 175, 200, 224, 303, 310, 395, 404, 483, 484, 485, 495,496, 497, 499, 562, 588, 603, 637, 831, 840, 843, antimalarial 561antioxidant 561antiplatelet aggregation 560cytotoxic 560, 561Epstein-Barr virus inhibition 560*Hernandia* species 588in human osteosarcoma^1^ 497in human osteosarcoma^2^ 497*in vivo* 499 of (EFEa) 831of 1α,25(OH)~2~D analogues 495of 1α,25-(OH)~2~D 495of 1α,25(OH)~2~D~3~ 496of 1α,25(OH)~2~D~4~ 499of capsaicin 200of discodermolide 4of *Escherichia coli* 843of EFE 840of *Ginkgo biloba* 172of *Hernandia nymphaeifolia* 562of *Hernandia* species 562of *Hernandia voyronii* 562of natural steroids 485of pironetin 26of polyphenols 224of polysaccharide (PS) 395of quinones 303of resorcinolic lipids 175of *Spirulina platensis* 404of triterpenes 637of vitamin D analogues 485of vitamin D~2~ 483, 484of vitamin D~2~ 484of vitamin D~3~ 483, 484of vitamin D~4~ 483, 484of vitamin D~5~ 483, 484of vitamin D~6~ 483, 484of vitamin D~7~ 483, 484of β-lapachone 310spasmolytic 561Biological processes 420 of ulosonic acids 420Biological role 422 of 3-deoxy ulosonic acids 422Biological studies 561 of genus *Hernandia* 561Biologically active glycolopoprotein complex (G-90) 485, 826 species of 826Biomedicine 827Biosynthesis 506 of ergosterol 506Bipolar disorder 369 effect of circadian activity on 369\[Bis(trifluoroacetoxy)iodo\]benzene 439 as reagent 439Bisbenzylisoquinoline alkaloid 584*Bixa orellana* 528 bixin from 528Bixin 528, 529 from *Bixa orellana* 528structure of 529Blood chylomicron 79 obesity induction 79Blood coagulation 70 role of serine protease in 70role of thrombin in 70Blood glucose 58 effect of *Ganoderman lucidum* 58elevation of 58Blood urea nitrogen (BUN) 784 levels in SHR 784Blood vessels 410Blood-brain-barrier (BBB) 786, 800, 813Blood-high-viscosity-syndrome 839 treatment of 839Blue crustacyanin 533Blue oxonium ions 531, 532 formation of 531*via* cyclic hemiketals 532*Bolivian algae* Metzger 139 oligomeric derivatives from 139Bolivianol 711 structure of 711Bone calcium mobilization 484 role of vitamin D~2~ in 484Bone mineral content (BMC) 499Bone mobilization 497 assay for 497*in vivo* 497Bone resorbing activity 495 of 1α,25(OH)~2~D~2~ 495of 1α,25(OH)~2~D~4~ 495of 1α,25(OH)~2~D~3~ 495Boron aldolate 23 *in situ* reduction of 23Bovine papillomavirus type 1 406 microbicidal compound against 406Bovine serum albumin (BSA) 837, 844 F-II hydrolysis of 837Bradycardia 194 due to opioids 194Bradykinin 191 as pain mediator 192Bradykinin B~2~ receptor 203 interaction with ginseng 203Brain 192, 383 COX3 enzyme in 192serotonin (5-HT) receptors in 383Brain development 375 serotonin (5-HT) 5A receptor in 375Brain enzymes 816 resistance to 816Brain membrane synaptosomes 814 radioligands from 814Brain neurons 371Brain processes 367 role of serotonin 367Brain stem 370 tryptophan hydroxylase (TPH) in 370Brazilian vassoura oil (*Baccharis dracunculifolia*) 721 composition of 721monoterpene hydrocarbons from 721nerolidol from 721oxygenated monoterpenes from 721oxygenated sesquiterpenes from 721sesquiterpene hydrocarbons from 721Brein 206 use in inflammatory skin conditions 206Brine shrimp bioassay 733Bromelain 840Bromoboronylether 214, 215 boron tribromide from 214conversion of 215α-(Bromomethyl)acrylate 470 condensation with 470Bromomethylethoxylate 4432-Bromothiazole 443Bronchitis 58, 88 *Ganoderman lucidum* in treatment of 58*Platycodon grandiflorum* in treatment 88Bulimia 369 effect of circadian activity on 369Bunyaviridae 410Bunya virus infection 410, 411 mouse model for 411treatment of 411Bupremorphine (18, 19-dehydrobupremorphine) 198 dehydroderivative of 198derivative of 198structure of 198Bursehernin 568, 592 as EBV inhibitor 592from *Hernandia cordigera* 568from *Hernandia guianensis* 568from *Hernandia ovigera* 568from *Hernandia ovigera* var. *mascarenensis* 568from *Hernandia peltata* 568Butyrolactone 220 biosynthesis of 220from *Aspergillus terreus* 220Butyrolactone II 220 from *Aspergillus terreus* 220structure of 220
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*E*-2-thiazolyl-α,β-enones 443Earache 205 use of *Psycotria colorata* in 205Earthwom 825, 840 as antipyretic 825as antitumor extract of 840as diuretic 825to treat clotting diseases 825use in folk remedy 825Earthworm chymotrypsinogen 830, 831 homologous sequences of 831Earthworm fibrinolytic enzymes 826, 832,836, 837, 839, 840, 843 as fibrinolytic agent 839as medicine 843as plasmin-activator 839biological function of 840from *Lumbricus rubellus* 826gene expression of 843immunological results of 840structure-based inhibitor modeling of 832substrate specificities of 837Earthworm fibronolytic enzyme EFE genes 843Earthworm fibronolytic enzymes (EFE) inhibitors 836 diisopropylfluorophosphase (DFP) as 836Earthworm plasminogen activator (e-PA) 826, 843Earthworm powder enzyme (EPE) 826, 843Earthworm serine protease 830Earthworm species 829 homologs from 829site-mutation in 829Earthworms 826 active components from 826Earthworm-tissue plasminogen activator (e-TPA) 826, 843EBV genome 592 expression of 592EBV inducer 592 *n*-butyrate as 592EBV inhibitor 5921,2,3,4-dehydrodeoxypodophyllotoxin as 5921,2,3,4-dehydropodophyllotoxin as 5926,7-demethylenedeoxypodophyllotoxin as 592 bursehernin as 592epimagnolin as 592*Hernandia ovigera* as 592podorhizol as 592EBV-EV activation 695 effect of *Tripterygium wilfordii* 695inhibition of 695Echinocystic acid 747 structure of 747Echinoderms 526ED-71492 synthesis of 492Edema 204, 317, 744 by 12-O-tetradecanoylphorbol-13-acetate (TPA) 317inhibition by hederagenin monodesmosides 204inhibition of 744EDTA 836Elkin-Ahn-Houk model 437 for asymmetric induction 437(+)-Efatine 566 from *Hernandia peltata* 566EFE 835, 838, 840--842 as plasminogen activator inhibitor 842assays of 835by photoreaction 841fibrinolytic medicine from 842in acute cerebral thrombosis 842in acute diseases 842in cerebrovascular thrombus 842in peripheral limbs arteriovenous thrombus 842in prevention of blood clotting 842in radiation therapy 841inhibition by fibrin 838role in dissolution of thrombus 842to treat AMI 842use of antitumor drugs 840EFE component A 829 from *Eisenia fetida* 829EFEa 830, 831 crystallization of 831homology of 830X-ray analyses 831EFE-B (*Lumbricus bimastus*)829, 830 secondary structure of 830EFE-immobilized polyurethane surface 841 as antithrombogenic agent 841effect on platelet activation 841effect on platelet adhesion 841EIMS 584, 587 of (-)-hernone 587of herveline A 583of ovihernangerine 584*Eisenia andrei* 828 from *Lumbricidae* family 828*Eisenia fetida* 826, 828, 829, 832 EFE component A of 829F-II homolog of 832fibrinolytic activity of 826from *Lumbricidae* family 828isozymes of 826ELAM-1 expression 70, 71, 291 baicalein effect on 291by TRAP 70induction by TRAP 70, 71Elastase 828, 832 characteristic of 832Elastatinal 836Electrically evoked contractions 801Electrochemical oxidation 537 electrochemical properties of 537Electrophiles 431Eleutherobin 5 as microtubule stabilizing agent 5ELISA 774*Elsholtzia stauntoni* 276 muxiangrin I from 276muxiangrin II from 276muxiangrin III from 276*Embelia schimperi* 3255-O-methylembelin from 325Embryonic central nervous system 378 role of serotonin (5-HT) in 378Embryonic intestinal receptor 494Emodin 306 structure of 306Encephalitis 408 vaccination against 408Endocannabinoid analogues 198 as cannabinoid ligand 198Endogenous peptide opioids 193 role of dynorphins 193role of endorphins 193role of enkephalins 193role of nociceptin 193role of OLR-1194role of opioid receptors 193Endomorphins 799ENDOR spectroscopic method 540 in free radical studies 540Endorphins 193 as endogenous peptide opioids 193Endothelial leukocyte adhesion molecule-1 (ELAM-1)70 expression of 70Endothelium 410Endothelium-dependent NO/EDFR 76 production of 76Enkephalins 193, 817 as endogenous peptide opioids 193analgesic activity of 817Enol ether 441 cleavage of 441Enolacetylation 486 of trienone 486α,β-Enone 444 derived from D-mannose 444ent-4α-hydroxy-19-nor-Beyer-15-ene 714 structure of 714ent-Beyer-15-en-17, 19-ol 714 structure of 714ent-Kaurenic acid 713 structure of 713ent-Kaurenol 713 structure of 713Enveloped virus 395, 401 inhibitor of 395Enzymatic oxidation 173 of lipids 173Enzymatic stability 816 of Tyr-D-Ala-Phe-Gly-Tyr-Pro-Thr-Gly-NH~2~ 816Enzyme 423, 430, 835, 840 for synthesis of carbohydrates 423inhibition of 154--156role of anacardic acids 154--156role of hydrolysis 835role of of fibrin 835role of of fibrinogen 835as specific properties of 840Enzymatic syntheses 423Enzymolysis 816EPA 65 from carp oil 6524*-epi-*1α,25(OH)~2~D~2~ 494 binding affinity of 494(+)-Epiaschantin 568, 590, 595 as platelet aggregation inhibitor 594activity in human cancer cell line 589activity in murine cancer cell line 589cytotoxic effect of 589from *Hernandia nymphaeifolia* 568from *Hernandia peltata* 568from *Hernandia* sp. 594Epicatechin 83 as tannin 8324-*epi*-D~2~ 490 synthesis of 49024-*epi*-D~6~ 490 synthesis of 490Epidermal cell culture 592 of BALB/c mice 592Epieudesmin 568 from *Hernandia peltata* 568Epigallocatechin 83 as tannin 83Epigallocatechin gallate 83 as tannin 83*Epilachna varivestis* 333Epileptic children 377(+)-Epimagnolin 568, 590, 595 as platelet aggregation inhibitor 594activity in human cancer cell line 589activity in murine cancer cell line 589cytotoxic effect of 589from *Hernandia nymphaeifolia* 568from *Hernandia ovigera* 568from *Hernandia peltata* 568from *Hernandia* sp. 594*Hernandia ovigera* var.*mascarenensis* from 568(+)-Epimagnolin A 568 from *Hernandia ovigera* 568Epi-Methyltrineracetal 708 structure of 708*Epipactis helleborine* 405(+)-Epiyangambin 569, 590, 593, 595 activity in human cancer cell line 589activity in murine cancer cell line 589as platelet aggregation inhibitor 594cytotoxic effect of 589from *Hernandia nymphaeifolia* 569from *Hernandia ovigera* 569from *Hernandia peltata* 569from *Hernandia* sp. 594use of soft agar transformation assay 593Epizootic infection 404 porcine HSV in 404Epothilone 5 as microtubule stabilizing agent 5Epoxidation 5061,2-Epoxy-1-(2-methoxyphenyl)-2-(4-methoxyphenyl)ethane 223 structure of 223α,β-Epoxy-aldehyde 473 synthesis of 473Epoxydibenzocyclooctene 226Epoxypironetin 27, 28 as mitotic arrester 27effect on G2/M phase 28structure of 28Epoxy-β-carotenes 840Epstein-Barr virus (EBV) 394, 592 in raji cells (EBV genome-carrying human lymphoblastoid cells) 592Epstein-Barr virus early antigen 592 activation inhibition of 592Epstein-Barr virus inhibition 560 due to lignans 560due to isoquinoline alkaloids 560Ergosterol 489, 506, 508 from lanosterol 506ozonolysis of 489Ergosterol biosynthesis 485Ergosterol derivative 506 22, 23-dihydroergosterol(provitamin D~4~) as 50624-*epi*-22, 23-dihydroergosterol(provitamin D~7~) as 506Eriodictyol 286 ^13^C-NMR data of 286Eriodictyol-3′,4′-dimethylether 746 structure of 746*Erythema infectiosum* 394Erythropoietic protoporphyria 524 use of β-carotene 524Erythroxanthin sulphate 526, 527 structure of 527*Escherichia coli* 739, 843 antibacterial activity against 739antifungal activity against 739biological activity of 843*Escobedria scabrifolia* 528 azafrin from 528Essential oil 605, 607 from *Hypericum hircimum* 607from limonene 607from nonane 607from α-gurjunene 607from α-pinene 607from β-pinene 607of hypericum 605Ethnobotanical studies 561 on genus *Hernandia* 561Ethnomedical system 732α-Ethoxyacrylonitrile 449 photolysis of 449Ethoxyvinyllithium 458 as reagents 4581-Ethoxyvinyllithium 458 reaction with 458ozonolysis of 458Ethyl 2-(bromomethyl)acrylate 451 nucleophilic addition of 451Ethyl 2-diazoacetate 446 reaction with 446Ethyl α-trifluoroacetoxy acrylatc 450 radical conditions 450reaction with 450(2S,3S)-2-Ethyl-3,4-isopropylidenedioxypropan-1-ol 39 from *L*-malic acid 39role in (-)-pironetin synthesis 39Ethylene diamine tetraacetic acid (EDTA) 844*Euclea natalensis* 328 isodiospyrin from 328*Euglena gracilis* 397 (1--3)-β-D-glucan from 397Euhypericum 610 hypericin from 609*Euonymus tingens* 668 tingenone from 668Eupatrin 726, 727 from *Baccharis genistelloides* *727*structure of 726*Euphorbia resinifera* 193 resiniferatoxin from 193Euphorogenic properties 194 of opioid 194Evans aldol-condensation 33 reaction 13Evans oxazolidinone-mediated*syn*-aldol condensations 44*exo*-enamine system 443*exo*-glycal 458 conversion to labile epoxide 458Expression 592 of EBV genome 592Extracellular polysaccharides 421Eye fatigue 64 use of carp in 64
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Family 560 of genus *Hernandia* 559Fast protein liquid chromatography 826Fatty acid 65 from carp oil 65uptake of 108Fatty liver 101 in mice 101Fear 376Fentanyl 198Fever 407Fever infections 410 by bunyaviridae family viruses 410F-I 826 as isozyme 826F-I-0826 as isozyme 826F-I-2826 as isozyme 826Fibrin 838Fibrin plate 827Fibrinogen 834, 838 conversion of 834fibrin from 834Fibrinolysis rate 841 effect of G-90841Fibrinolytic activity 826, 827 from earthworm *Eisenia fetida* 826Fibrinolytic agent 839 in disease prevention 839in treatment of clotting disease 839in acute myocardial infarction 839in cerebral thrombus 839Fibrinolytic effect 840 of lyophilized powder 840Fibrinolytic efficacy 839*in vitro* 839Fibrinolytic enzyme 825, 827, 839 from *Lumbricus rubellus* 825from *Lumbricus bimastus* 827in thrombosis treatment 839recombinant prourokinase (pro-UK) as 839recombinant tissue-type plasminogen activator as 839staphylokinase as 839streptokinase (SK) as 839urokinase (UK) 839Fibrinolytic mechanism 837Fibrinolytic medicine 842 activity of 842half life of 842immunogencitity of 842properties of 842re-occlusion rate of 842Fibroblast growth factor 56 angiogenesis by 56F-I-I 826 as isozyme 826F-II 830, 836, 838 C-terminal region of 838inhibition of 836N-terminal region of 838secondary structure of 830F-II *(Lumbricus rubellus)* 829F-II alias EFEa 826F-II cleavage 838 of human plasminogen 838F-II homolog 832 from *Eisenia fetida* 832F-II hydrolysis 837 of bovine serum albumin (BSA) 837of creatine kinase (CK) 837of immunoglobulin G (IgG) 837F-III 826 as isozyme 826F-III-1 826, 828, 830, 833, 836 as isozyme 826caseinolytic activity of 833inhibition by Soybean trypsin inhibitors (SBTI) 836inhibition of 836*N*-terminal sequences of 828 secondary structures of 830F-III-1 (2)831 homologous sequences of 831F-III-2 826, 828, 830, 833 as isozymes 826fibrinolytic activity of 833*N*-terminal sequences of 828 secondary structures of 830First-order kinetics 786Flavone glycosides 235 acidic hydrolysis of 235enzymatic hydrolysis of 235sugar moieties of 235Flavones 236, 285 ^13^C-NMR spectral data of 285UV spectra of 236Flavonoid p-coumaroyl glycosides 274 genkwanin from 274Flavonoids 56, 70, 233, 234, 238, 241, 272--277, 284--285, 619, 628, 629, 724, 725, 562 against *Staphyllococcus aureus* 629anti-thrombic actions of 70as glycosides 724biogenetically formation of 233from *Baccharis grisebachii* 725from *Hernandia* sp. 562from luteolin 619from miscellaneous genera272--277from *Scutellaria baicalensis* 56^1^H-NMR spectra of 238, 284 identification of 234, 235inhibitory activity of 629isolation of 233--236, 619methoxyl protons of 241purification of 233, 234wound-healing effect of 628Flavonol 616 amentoflavone 616biflavones 13-biapigenin 616glycoside derivatives 616hyperoside 616isoquercitin 616quercitin 616rutin 616Flu 691 *Maytenus amazonica* for 691Fluorescent antibodies 8416-Fluoroheptulosonic analogues 473Fluorosulfonic acid 215 1-Fluoro-tetrahydrocannabinol 1965-Fluorouracil 56 side effects of 56Folk medicine 203, 603 from genus *Hypericum* 603use of ginseng root in 203Formalin 205 inflammatory pain induction by 205neurogenic pain induction by 2057-Formyldehydrohernangerine 563, 589 activity in human cancer cell line 589cytotoxic effect of 589from genus *Hernandia* 563from *Hernandia nymphaeifolia* 5637-Formyldehydronornantenine 563, 589 activity in human cancer cell line 589activity in murine cancer cell line 589cytotoxic effect of 589from genus *Hernandia* 563from *Hernandia nymphaeifolia* 5637-Formyldehydroovigerine 563 from genus *Hernandia* 5637-Formyldehydroovigerine 563 from *Hernandia nymphaeifolia* 5637-Formyldehydroovigerine 581 ^1^H-NMR spectrum of 581HREIMS of 581hydrogen-bonding of 581IR spectrum of 581isolation of 581molecular formula of 581UV absorptions of 5817-Formyldehydroovigerine 589 activity in human cancer cell line 589activity in murine cancer cell line 589cytotoxic effect of 589Fragile X syndrome 374 and environmental factors 374and genetic considerations 374autistic features in 374Free radicals 221, 224 production of 321role in aging 224role in atherosclerosis 224role in cancer 224role in cardiac diseases 224role in diabetes 224role in human diseases 224role in inflammation 224role in intestinal diseases 224role in neurodegeneration 224role in reperfusion injuries 224role in respiratory disorders 224Fridelane-type triterpene 697Friedelanes 638--645 from celastraceae 638--645translocation of 639Friedel-Crafts reaction 214 Kagan\'s ethers by 214Friedelin 719 structure of 719Friedelinol 719 from *Baccharis linearis* 719from *Baccharis rhomboidalis* J. 719from *Baccharis solieri* D.C. 719Frontal cortex 377 serotonin synthesis in 377Fucoidan 55--57, 399, 405 against human CMV 405antitumor activity of 56as antiviral agent 405effect on angiogenesis 56effect on body 56, 57effect on liver metastasis 55effect on spleen or adipose tissue weight 56, 57effect on thymus 56, 57effect on tumor growth 55--57from *Fucus vesiculosus* 399from *Laminaria japonica* 56Fucoxanthin 531Fucoxanthin oxonium ion 518, 519 structure of 519*Fucus vesiculosus* 399 fucoidan from 399Functional bioactivity 813 of \[Tyr)Me)~2~-Phe\] peptides 813of Tyr(Me)~2~-Phe-NH~2~ 813of d-Tyr(Me)~2~-Phe-NH~2~ 813of Tyr(Me)~2~-d-Phe-NH, 813of d-Tyr(Me)~2~-d-Phe-NH~2~ 813of Tyr(Me)~2~-Phe-G-V-V-NH~2~ 813of d-Tyr(Me)~2~-Phe-G-V-V-NH~2~ 813of Tyr(Me)~2~-d-Phe-G-V-V-NH~2~ 813of d-Tyr(Me)~2~-d-Phc-G-V-V-NH~2~ 813Fungal polysaccharide (PS) 412 *in vivo* 412Furan ring 456 oxidative degradation of 4561-Furano glycal derivative 455 conversion into 455Furanoid 570Furanonaphthoquinones 314Furanoxides 530Furoclerodanes 709Furofuran lignans 594 antiplatelet activity of 594Furohyperforin 611, 613 structure of 613Furohyperforin hydroperoxide 611, 613 as artifacts 611structure of 6132-Furoic acid 456Furolabda-7-en-17-oic acid 713 structure of 713Furosin 208 analgesic effect of 2082-Furyllithium 458*Fusarium* 163, 717 by trichothecene mycotoxins 717from soil fungi 717Functional bioassay 809 activity of Tyr-Tic-NH~2~ in 809activity of (Tic^2^, Leu^5^)enkephalin in 809activity of (Tic^2^)dermorphin in 809activity of (tic^2^)DYN-A-(1--11)-NH~2~ in 809activity of (Dmt~1~, Tic~2~)DYN-A-(1--11)-NH~2~ in 809activity of (D-Ala,des-Gly~2~)DYN-A**-(1**-11)-NH~2~ in 809activity of DYN-A-(1--11)-NH~2~ in 809activity of (tic^2^)DYN-A-(1--13-)-NH~2~ in 809Furolabda-6,8-dien-17-oic acid 712 structure of 712Formalin test 207 activity of 13-narin-II8--4′-OMe-eridictoyol in 207role of biflavonoid 207
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G-90841 as α plasminogen activator 841GABA 627, 782, 783, 787 effect on blood pressure 783effects of glutamic acid decarboxylase (GAD) 783effects of hyperforin inhibitor 627hypotensive effect of 782in spontaneously hypertensive rats 783in systolic blood pressure in SHR 783metabolism of 783occurrance of 782oral administration of 783systemic administration of 782GABA~A~ receptor 203 interaction with ginseng 203GABA ~B~ receptor 203, 787 effect in SHR 787interaction with ginseng 203GABA-rich *Chlorella* 783GABA-transaminase 783*Galeopsis angustifolia* 273 isoscutellarein from 273Gallic acid 208 analgesic effect of 208derivatives of 208design of 208Ganoderic acid F (12-acetoxy-3,7, 11, 15, 23-pentaoxolanost-8en-oic acid) 64 angtiangiogenic effects of 63^13^C-NMR of 64effects of 63effects on hemoglobin 63^1^H-NMR of 64 IR data of 64MS analyses of 64structure of 64*Ganoderma lucidum* 56, 58, 60 antimetastatic effect of 58, 60antitumor effect of 58effect on blood glucose 58in treatment of arteriosclerosis 58in treatment of arthritis 58in treatment of bronchitis 58in treatment of cancer 58in treatment of diabetes 58in treatment of hyperlipidemia 58in treatment of hypertension 58triterpenoid fractions of 60triterpenoid from 56Gas phase B3LYP calculation 549Gastrointestinal depression 799 due to analgesic alkaloid 799Gastrointestinal diseases 56, 691, 747 use of *Maytenus amazonica* for 691Gastrointestinal toxicity 56 due to cancer drugs chemotherapy 56Gastrointestinal tract (GITI) 786Gaudichaudols A-C 734 structure of 734Gaudichaudone A 734 against certain cancer cells 734G-coupled proteins 808 interaction of 808phosphorylation of 808Gel filtration 825, 826 enzyme isolation by 825Gemixanthone 622 from *Hypericum geminiflorum* 622Gene engineering 842Gene expression 373 in regulation of methyl CpGbinding protein 373Gene SLC18A2380 role in vesicular monoamine transporter type 2 (VMAT2)380Genetic duplication 370 of ancestral gene 370Genetically transformed madder 343 elicitation of 343Genital warts 405Genkwanin 727 from *Baccharis genistelloides* 727structure of 727Genotoxic agent 316 from *Rubia tinctorum* L. 316Genus 560 of *Hernandia* 559Genus *Baccharis* L. 703 from biologically active substances 703Genus *Hernandia* 563--580 (-)-laetine from 564(+)-actinodaphnine from 563(+)-corytuberine from 563(+)-hernagine from 563(+)-hernandaline from 563(+)-hernovine from 564(+)-isoboldine from 564(+)-isocorydine from 564(+)-laurotetanine from 564(+)-magnoflorine from 564(+)-*N*-formyldehydroovigerine from 563(+)-*N*-formylnornanteninc from 563**(+)-N**-formylovigerine from 563**(+)-N**-hydroxyhernangerine from 564(+)-*N*-methyl-6,7-dimethoxyisoquinolone from 564(+)-*N*-methylactinodaphnine from 5645,6-Dimethoxy-*N*-methylphthalimide from 5636,7-dimethoxy-*N*-methylisoquinoline from 5637-formyldehydrohernangerine from 5637-formyldehydronornantenine from 5637-formyldehydroovigerine from 5637-hydroxy-6-methoxy-1-methylisoquinoline from 564alkaloids from 563antiplatelet aggregation effect of 560atheroline from 563backebergine from 563benzenoids from 567constituents of 563--570dehydrohernandaline from 563demethylsonodione from 563*Hernandia cordigera* sp. 563*Hernandia guianensis* sp. 563, 564*Hernandia nymphaeifoiia* sp. 563, 564*Hernandia ovigera* sp. 563, 564*Hernandia ovigera* var.*mascarenensis* 563, 564*Hernandia peltata* sp. 564*Hernandia sonora* sp. 563, 564*Hernandia voyronii* sp. 564hernandonine from 564hernangerine from 564hernanymphine from 564isoindole from 563isoquinoline from 563--567laetanine from 564laudanosine from 564lignans from 567lindearpine from 564monoterpene from 569*N*-(N-methylcarbamoyl)-O-methylbulbocapnine from 564*N*-formylnornantenine from 563*N*-hydroxyovigerine from 564*N*-methylcorydaldine from 564pyridine from 567sterols from 569--570structures of 571--580Genus *Hypericum* 607, 619 hypericin from 607isohypericin from 607pseudohypericin from 607xanthones 619Genus *Ononis* 138 resorcinolic from 138Geraniin 208 analgesic effect of 2089-Geranyl-α-terpineol 615 structure of 615Germacrane D 607, 715, 722 from *Baccharis dracunculifolia* D. 715structure of 722Giganteones 152 from *Myristica gigantea* 152*Gigartina skottsbergii* 402 carrageenans from 402Gingerols 193 from *Ginger* species 193Ginseng 203 activity in chronic pain model 203as analgesic 203interaction with bradykinin B~2~receptor 203interaction with GABA~A~ receptor 203interaction with GABA~B~ receptor 203interaction with neurokinin NK~1~receptor 203Ginseng root 203 use in abdonminal pain 203use in chest pain 203use in folk medicine 203use in neuralgia 203use in pain 203use in toothache 203Ginseng saponins 203 action of 203Ginseng sp. 203 *Panax ginseng* 203*Panax japonicus* 203*Panax quinquefolius* 203Ginsenosides 203 action of 203effect on central nervous system 203effect on nociception 203effect on spinal region 203effect on supraspinal region 203steroid-like structure of 203TRPVI receptor blockade by 203voltage-sensitive calcium channels blockade by 203Globulol 724Gluconate 431 degradation of 431Gluconolactone 4474′-β-D-Glucopyranosyl 4-hydrogen-7′,8′-dihydro-4,4′-diapocarotene-4,4′-dioate 528Glucosamine 95Glucose 58Glucose transporter 817Glutamate 192, 193 as pain mediator 192as pro-nociceptive 193fibres 192\[^3^H\]-Glutamate 208Glutamate receptors 208Glutinanes 65Glycals 453--458 homologation of 455syntheses from 453--458Glyco analogues activity 817 *in vivo* 817Glycoenkephalins 817Glycopeptides 815 *in vitro* 815Glycoprotein 841 from earthworm 841Glycosides 203Glycosilated benzophenone 624 from *Hypericum* sp. 624α-Glycosylation 457Glyoxylate carboanion 452Glyoxylic acid ester 466*Glyptopetalum sclerocarpum* 656, 668, 670 20-hdroxy-22-oxo-20-epi-tingenone from 67020-hydroxy-22-oxotingenone from 67021α-hydroxy-20, 22-dioxo-30(20→21)abeo-21-desoxotingenone from 670glyptopetolide from 656Glyptopetolide 656 ^13^C NMR spectral data of 656from *Glyptopetalum sclerocarpum* 656^1^H-NMR spectrum of 656HMBC spectrum of 656NOESY experiment of 656stereochemistry of 656structure of 656, 657GM-CSF 771 expression pattern of 771Gorrichton\'s synthesis 472 of 3-deoxy-D-arabino-2-heptulosonic acid 472GPI assay 807, 812 activity of k-agonist U-50, 488 in 807activity of Tyr-(Me)~2~-D-Phe-Gly-Val-Val-NH~2~ in 812activity of Tyr-(Me)~2~-D-Phe-NH~2~in 812GPI bioassay 814 activity of glycopeptide 814G-protein 383 effects on inositol phosphate hydrolysis 383elevation of cytosolic Ca^++^ by 383inhibition of cAMP formation by 383G-protein coupled-receptor 383, 384 association with behavioral phenotypes 384Gram-negative bacteria 693 *Maytenus* species against 693Gram-positive bacteria 629, 693 antimicrobial activity of 629*Maytenus* species against 693Grignard reagent 30Growth 61 of tumor cells 61Grubbs ruthenium catalyst 463GTP analogue 208Guinea pig brain membranes 807 μ-affinity in 807Guinea-pig ileum bioassay 802 *in vitro* 802activity of μ-opioid receptor in 802Gurjar\'s syntheses 33--37 of (-)-pironetin 33--37
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Ibuprofen 192 as cyclooxygenase enzyme (COX) inhibitor 192ICAM-1 expression 70, 71 inhibitory effect on 70, 71ICI 199441812 molecular model of 812IFNγ 770, 775, 776, 778 cytokine expression patterns of 775expression of 776levels of 775IgE production 773 inhibition of 773against casein 773Iguesterine 665, 667 from *Maytenus canariensis* 667structure of 665IL-10775 cytokine expression pattern of 775IL-12 770, 771, 772, 775, 776 cytokine expression of 775expression of 772, 776from macrophages 770levels of 775stimulation of NK cell by 770stimulation of Th1 cell by 770IL-12 p40 779, 780 in response to ARS-2780in TLR4-dificient C3H/HeJ mice 779with ARS-2779IL-12 p40 mRNA 779 in spleen culture 779levels of 779IL-12 p40 production 778, 780ARS-2-mediated-780 by spleen-adherent cells 778, 780by spleen-adherent cells of mice 778*in vitro* 778 with ARS-2778IL-1α 689, 771 expression pattern of 771inhibitory activity of 689IL-1β689 inhibitory activity of 689IL-2 production 782 by macrophages/dendritic cells 782by TLR2 signaling 782IL-6775 cytokine expression pattern of 775Imanine 628 antibacterial propertiesof 628Immune disorders 484 use of 1α,25(OH)~2~D~3~ 484Immune response 766, 770 against *Listeria monocytogenes* 770by αβ T cells 766Immunization 408 against measles 408Immunodeficiency syndrome 226, 394 causative agent of 394Immunodeficiency viruses 397 use of HIV-1397use of HIV-2397Immunodulatory activity 395 of polysaccharide (PS) 395Immunoglobulin G 837F-II hydrolysis of 837Immunological role 422 of 3-deoxyulosonic acids 422stereocontrolled chemical syntheses in 422Immunopharmacology 766 of *Chlorella* 766of green algae 766Immunosuppressive agent 3 discodermolide as 3pironetin as 3Immunosuppressive disease 396Immunosuppressive effect 26 on blastogenesis 27of pironetin 26Immunotoxicity 56 due to cancer drug chemotherapy 56*In vitro* 59, 61, 396, 594, 596, 810, 815 antiplasmodial activity of 596antiplasmodial activity of chloroquine 596antiplatelet aggregation turbidimetry assay 594DNA synthesis 61 glycopeptides 815HIV replication 396Lewis lung carcinoma 59 receptor binding assay 810*In vitro* activities 816 of glycopeptides 816*In vitro* bioassay 591 for chemopreventive activity 591*In vitro* studies 203 of ginseng extract 203of ginsenosides 203*In vivo* studies 61, 195, 593, 597, 805, 815 anandamide 195angiogenesis 61antinociception 805chloroquine potentiating antiplasmodial activity 597glyco analogues activity 817herveline A 597mouse fail-flick assay 815parasitemia inhibitor 597tetrahydrocannabinol (THC) 195tumor-promotion 593Incarvillateine 204 as antinociceptive agent 205from *Incarvillea sinensis* 204inflammatory pain inhibition by 205neurogenic pain inhibition by 205*Incarvillea sinensis* 204 incarvillateine from 204Indomethacin 192 as cyclooxygenase enzyme (COX) inhibitor 192Infantile autism 376 hippocampal neurons in 376Inflammation 192, 224, 225, 732 COX-2 enzyme in 192pro-nociceptive prostaglandins in 192role of free radicals in 224role of leukotrienes in 225Inflammation mediators 225 leukotrienes as 225Inflammatory disorder 192 treament by COX-2 inhibitor 192Inflammatory genes 319 COX-2 as 319expression of 319interleukin-2 as 319interferon-γ as 319TNF-α as 319Inflammatory pain 205, 204 induction by formalin 205inhibition by incarvillateine 204Inflammatory skin condition 206 use of brein in 206use of amyrin in 206Influenza 407 therapy of 407preventive medicines for 407use of phytochemicals in 407Influenza virus 289, 395, 407, 408 *in vitro* 408inhibitor of 395Influenza virus replication 408 effect of sulphated polysaccharide (PS) 408Inhibitors 836 of EFEs 836Inhibitory activity 629 action mechanism of 225against *Staphyllococcus aureus* 629*Bacillus subtilis* 629caffeic acid inhibition by 225from *Hypericum drummondii* 629of drummondins A-C 629of phloroglucinols 629of *Mycobacterium smegmatis* 629role of 225Inhibitory effect 396, 594, 801*in vitro* 396 of DAGO 801of dermorphin 801of *Hernandia* sp. 594of morphine 801of δ-agonists 801on HIV replication 396Inhibitory mechanisms 318 of emodine 318Insecticidal activity 153--154, 695 of anacardic acid 153--154of quinone methides 695Integrase 226 cleaveage of 226role in HIV 226Interferon gamma (IFN-γ)689 inhibitory effect on 689production of 689Interleukin-1 (IL-1)689 by synovium 689production of 689Intestinal calcium transport 484, 497 assay for 497of 1α,25(OH)~2~D~3~ 497role of vitamin D~2~ in 484Intestinal diseases 224 role of free radicals in 224Intrinsic activity 596, 816*in vivo* 596 of alkaloids 596of central opioid receptors 816of DER 816of glycopeptides 816Inulin 90, 92 from *Platycodi radix* 92Ionotropic receptor 192, 193 heat-activated channel TRPVI type of 193role in nociceptor depolarisation 192role in tetrodotoxin-resistant sodium channels 193role in vanilloid receptors 193TRPM8 type of 193IR spectrum 570, 581, 582, 584, 587 7-formyldehydroovigerine 581of (-)-6′-hydroxyyatein 587of (-)-hernone 587of (+)-*N*-formylovigerine 582of demethylsonodione 570of ernamymphine 582of ovihernangerine 584Iron (III) reductors 225NDGA as 225Irritable bowel syndrome 368 role of serotonin (5-HT) 368Isobaccharin 737 structure of 737Isobaccharinol 736 structure of 736(+)-Isoboldine 564 from *Hernandia cordigera* 564from genus *Hernandia* 563Isocarotene 544(+)-Isocorydine 564 5,6-dimethoxy**-** ***n***-methylphthalimide 563from *Hernandia cordigera* 564from genus *Hernandia* 563Isoiguesterine 665, 667 from *Salacia madagascariensis* 667structure of 665Isoiguesterol 693--695 against drug-sensitive strain NF~54~ 694against multidrug-resistant strainK1694 structure of 695Isoindole 562, 563 from genus *Hernandia* 563from *Hernandia* sp. 562Isojacareubin 620 from hypericum 620Isoprenoid quinones 304 in arthropods 304in sea lichens 304Isopropylidene-D-glyceraldehyde 469 addition of 4692,3:5,6-di-O-Isopropylidene-D-mannose 452 nucleophilic acylation of 452Isoquinoline 563--567, 588 against cancer cell lines 588from genus *Hernandia* 563--567Isoquinoline alkaloids 560, 562, 588, 590, 594, 597(+)-corytuberine 589(+)-hernovine 589(+)-laurotetanine 589(+)-magnoflorine 589(+)-*N*-formyldehydroovigerine 589(+)-*N*-formylnornantenine 589(+)-*N*-formylovigerine 589(+)-*N*-hydroxyhernangerine 589(+)-*N*-methylhernangerine 590(+)-ovigerine 5907-formyldehydrohernangerine 5897-formyldehydronornantenine 5897-formyldehydroovigerine 5897-hydroxy-6-methoxy-1-methylisoquinoline 5897-oxohernagine 590against cancer cell lines 588antiplatelet aggregation activity of 560cytotoxicity of 560demethylsonodione 589Epstein-Barr virus inhibition due to 560from genus *Hernandia* 560from *Hernandia* sp. 562hernandonine 589hernanymphine 589N-hydroxyovigerine 589N-methylcorydaldine 589N-methylovigerine 590thalifoline 590Isovanillin 567, 594 as platelet aggregation inhibitor 594from *Hernandia sonora* 567from *Hernandia* sp. 594Isovelleral 193 from *Ginger* species 193Isozymes 827, 828, 843, 826, 829 F-I as 826F-I-0 as 826F-I-2 as 826F-II as 826F-I-I as 826F-II as 843F-III as 826F-III-1 as 826, 843F-III-2 as 826, 843from *Eisenia fetida* 826from *Lumbricus bimastus* 827from *Lumbricus rubellus* 826immunological analyses of 829
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JB6 cell line 593 tumor-promotion in 593JB6 cell line transformation 592 inhibition of 592Juglone 313 structure of 313
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Kaemferol 224 from natural flavonol 224Kagan\'s ether 215 cyclisation of 215mechanism of formation of 215k-agonist U-50, 488 807 activity in GPI assay 807*Kalopanax pictus* 203 use in folk medicine 203use in rheumatoid arthritis 203Kalopanaxsaponins-A 203 antinociceptive effect of 204Kalopanaxsaponins-I 203 antinociceptive effect of 204kappa-opioid receptor 205 activation by (+)-allomatrine 205activation by(+)-matrine 205kappa-opioid receptor activation 207 by menthol 207Kawada\'s synthesis 30--33 of (-)-pironetin 30--33KB cells cytotoxicity assay 733 determination of cytotoxic activity 733KB-16 (human oral epidermal carcinoma) 588 activity of (-)-deoxypodophyllotoxin against 588activity of (-)-yatein against 588KCI-depolarized rat portal vein 748KDG 441, 431 from glyceraldehyde 431synthesis of 431KDN 421, 422, 433, 440, 444, 448, 462 configuration of 463conversion 462and D-mannose 433from membrane polysialoglycoproteins 422from non-carbohydrate sources 462from oxalacetic acid 433from rainbow trout eggs 422in cancer cells 422in human fetal card red blood cells 422oncotetal antigen properties of 422preparation of 440structure of 421synthesis of 444, 448total synthesis of 462KDO 421, 441, 449, 465, 471Augé synthesis of 465 debenzylation of 441hydrogenolysis in 441intramolecular cyclization of 441modifications of 465Pettus synthesis of 471 structure of 421synthesis of 441*via* cobaltoxime 449KDO aldolase 430 from *Auereobacterium barkerei* 430KDO analogs 430 synthesis of 430KDO derivative 433, 438, 455 anomeric mixture of 433KDO synthesis 448, 450, 456 photochemical 448radical cross-coupling in 448radical elongation process in 450*via* exo-glycals 456KDPG aldolase 431*in vivo* 431KDPG aldolase action 431*in vivo* 431Keck\'s synthesis 42--44 of (-)-pironetin 42--44Ketal derivatives 214O-condensation of 214Ketene dithioacetals 459 oxidative hydrolysis of 4592-Keto-3-deoxy-6-phosphogluconate (KDPG) aldolase 424 structure of 4242-Keto-3-deoxy-gluconate (KDG) aldolase 424 structure of 424Ketone 44, 451 cyclization of 451ozonolysis of 451reduction of 44Kidney disturbances 207 use of *Phyllanthus* (genus) in 207Kinin formation 204 inhibition of 204Kitahara\'s synthesis 40--42 of (-)-pironetin 40--42K~m~ values 95 of lipase activity 95KO 421 structure of 421Koenigs-Knorr type reaction 467 glycosyl donors in 467*Kokoona zeylanica* 642, 674 celastrahydride from 642zeylasterone from 674Kotalagenin 16-acetate 645^13^C NMR data of 645 from *Salacia oblonga* 645^**1**^ **H** NMR data of 645HMBC spectrum of 645NOESY spectrum of 645 stereochemistry of 645Kotalagenin 16-acetate 645 structure of 645
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Labiatae flavonoids 277--283 ultraviolet spectra of 277--283Lactagogue 72*Angelica keiskei* use as 72β-Lactoglobulin 840Lactone 17, 457 hydroboration-oxidation reaction of 457synthesis of 172,3-seco-22, 29-Lactone-oleane-12-ene-2,3-dioic acid 3 -methyl ester 650 structure of 650Laetanine 564 from genus *Hernandia* 563from *Hernandia voyronii* 564(-)-Laetine 564 from genus *Hernandia* 563from *Hernandia peltata* 564*Laminaria abyssalis* 400 sulphated polysaccharide (PS) from 400*Laminaria japonica* Aresch. 56 fucoidan from 56in arteriosclerosis treatment 56in cancer treatment 56in hyperlipidemia treatment 56Lapachol 317 teratogenic potential of 317Lapachone 310 structure of 310Laryngitis 88 use of *Platycodon grandiflorum* in 88Laudanosine 564, 595, 596 antimalarial activity of 595antiplasmodial activity of 596effect on antiplasmodial activity 596from genus *Hernandia* 563from *Hernandia voyronii* 564Laulimalide 5 as microtubule stabilizing agent 5Laurales 560 order of 560(+)-Laurotetanine 563, 564, 589, 594 activity in human cancer cell line 589activity in murine cancer cell line 589as platelet aggregation inhibitor 594cytotoxic effect of 589from genus *Hernandia* 563from *Hernandia cordigera* 564from *Hernandia guianensis* 564from *Hernandia nymphaeifolia* 564from *Hernandia* sp. 594Lawsone 314 structure of 314*Lawsonia inermis* 336 for decoration 336Laxative 72 use of *Angelica keiskei* as 72Laxative activity 304--307 of anthranoid compounds 304--307Laxative drugs 303 aloes as 303caseara as 303rhubarb as 303senna as 303Laxative effect 305 of aglycones 305by damaging epithelial cells 305LDL peroxidation 224 induction by AAPH 224induction by Cu^2+^ 224*Leathesia difformis* 405Ledene 715 from *Baccharis dracunculifolia* D. 715*Leonurus cardiaca* 273 isoquercitrin from 273Leukocyte degranulation 70 inhibitory action on 70Leukocytes 59, 60, 64, 66, 67, 70 effect of carp oil on 66effect of oleic acid on 65effect of triterpenoid fraction on 60in LLC-bearing mice 59, 64inhibitory action on 70Leukotriene B~4~ 70 inhibitory action on 70Leukotriene biosynthesis 225 inhibition of 225Leukotrienes 192, 225 and macrophages 192as pain mediator 192from arachadonic acid 225LTC~4~ type of 225LTD~4~ type of 225LTE~4~ type of 225 peptidoleukotrienes type of 225role in allergy processes 225role in inflammation 225Lewis lung carcinoma 59*in vitro* 59Lichenan polysaccharide (PS) 412 from moss 412Ligand 799, 808 of opioid system 799opioid receptivity of 808Ligand-gated ion channel 378Light receptor molecules 369 role of tryptophan 369Lignan constituents 588 against cancer cell lines 588Lignans 560, 562, 567, 570, 590, 594(-)-deoxypodophyllotoxin 589(-)-hernone 590(-)-nymphone 590(-)-yatein 590(+)-epiaschantin 590(+)-epimagnolin 590(+)-epiyangambin 590 activity in antiplatelet aggregation turbidimetry assay 594antiplatelet aggregation due to 560aryltetralin lactone 570cytotoxicity due to 560dibenzylbutyrolactone 570Epstein-Barr virus inhibition due to 560 from genus *Hernandia* 560, 567from *Hernandia* species 590furanoid 570Limbic brain regions 383 serotonin (5-HT) receptors in 383Limonene 723 structure of 723Lindearpine 564 from genus *Hernandia* 563from *Hernandia voyronii* 564Linoleic acid 65 from carp oil 65Lipid emulsion 88, 104 administration of 104oral administration of 88Lipid metabolism 80 role of tea 80Lipid peroxidation 80 inhibition by epicatechin gallate 80inhibition by epigallocatechin gallate 80inhibition by epigallocatechin 80Lipid-soluble antioxidant 322 uniquinone as 322Lipophilic analogue 224 of vitamin C 224Lipophilic antioxidant 224 design of 224Lipopolysaccharides (LPS) 420 components of 420of gram-negative bacteria 420role in immunospecificity 4205-Lipoxygenase 225 redox inhibitors of 2255-Lipoxygenase enzyme (5-LO) 2255-Lipoxygenase inhibition 225 effect of polyhydroxylated 2-phenylnaphthalenes 225effect of tetrahydroxypavinan 2255-Lipoxygenase inhibitors 226IC~50~ values of 226*Listeria* infection 766, 768 host defense against 766late phase of 769protective mechanism against 766stage of 768with LP-BM5 MuLV 766with murine leukemia viruses 766*Listeria monocytogenes* 766, 767, 773 host defense against 766in immune response 773*Listeria**-specific*** antigens 770Listeria-specific cell-mediated immunity 768 development of 768Lithiated 2-acetylthiazole 4372-Lithiofuran 469 addition of 469(E)-Lithium enolate 25, 469 oxidation of 469Lithospermic acid A 227 as HIV-1 integrase inhibitors 227structure of 227Lithospermic acid B 227 as HIV-1 integrase inhibitors 227structure of 227Lithospermic acids 226 effect on HIV-1 infected **H9** cells 226*Lithospermun erythrorthizon* 345BK**-39** callus culture of 345Liver 64 metastasis in 64Liver carcinoma 406Liver disorders 637 role of oleanolic acids in 637Liver hepatocytes 406Liver injury 637 role of oleanolic acids in 637Liver metastatic tumor colonies 66 effect of oleic acid on 65Liver necrosis 406Liver triglyceride 81 accumulation of 81Liver tumor model **(H** ~**22**~ **)** 841 effect of *Eisenia fetida* 841Livestock 751 toxic disease 751LLC cells 65 intrasplenic implantation of 65LLC cells DNA synthesis 67, 68 effect of oleic acid on 67, 68LLC tumor metastasis 60 effect of triterpenoid fraction on 60inhibition of 60LLC-bearing mice 59, 61 leukocytes in 59tumor in 61L-malic acid 38, 39 (2S,3S)-2-ethyl-3,4-isopropylidenedioxypropan-1-ol from 39role in (-)-pironetin synthesis 38Lofentanil 200 as morphine analogue 200Longitin 285^**1**^ **H**-NMR spectral data of 285Loperamide 200 antidiarrheoal activity of 200Loreainide 200 antiarrhythmic activity of 200Low TEQ compounds 765 chlorophyll effect on 765LPS 777 from gram-negative bacteria 778L-quebrachitol 38 role in (-)-pironetin synthesis 38LTC~4~ 225 type of leukotrienes 225LTD~4~ 225 type of leukotrienes 225LTE~4~ 225 type of leukotrienes 225Lugworm (*Arenicola marina*) chymotrypsinogen 830, 831EFEa from 830 homologous sequences of 831*Lumbricus* 828 from *Lumbricidae* family 828*Lumbricus bimastus* 827, 828 from *Lumbricidae* family 828isozymes of 827*Lumbricus castaneus* 828 from *Lumbricidae* family 828*Lumbricus rubellus* 825, 840 lyophilized powder of 840*Lumbricus rubellus* (humus earthworm) 826--828, 833 assay of 833earthworm fibrinolytic enzymes from 826from *Lumbricidae* family 828isozymes of 826*Lumbricus terrestris* (common earthworm) 828 from *Lumbricidae* family 828Lupane caffeoyl esters 646 from *Celastrus stephanotifolius* 646from *Hippocratea volubilis* 646Lupane triterpenes 645 from celastraceae family 645Lupeol caffeate 646 from *Hippocratea volubilis* 646stereochemistry of 646ROESY experiment of 646 structure of 646Lupeol caffeate 646 from *Hippocratea volubilis* 646Lutein 525 structure of 525Lutein 3′-methyl ethers 546 formation of 546from lutein 546Luteolin-7,3′-dimethylether 745, 746 structure of 745L-xylo-heptulosonic acid 434 stereoselective synthesis of 434Lycopene 525 structure of 525in prostate cancer prevention 525Lymphocyte 60 accumulation of 60around tumor cells 60Lytic plaques 404

M {#cesec130}
=

Macrocyclic trichothecenes 751*in vivo* toxicity of 751 inhibition of protein synthesis 751paralysis of skeletal muscles due to 751respiratory depression due to 751α~2~-Macroglobulin 836 aspartate inhibition by 836cysteine inhibition by 836metallo-proteases inhibition by 836serine inhibition by 836Magnetic resonance imaging (MRI) studies 375, 384 of autistic children 375(+)-Magnoflorine 564, 589 activity in human cancer cell line 589activity in murine cancer cell line 589cytotoxic effect of 589from genus *Hernandia* 563from *Hernandia nymphaeifolia* 564Malaria 561, 597 use of *Hernandia moerenhoutiana* in 561use of *Hernandia moerenhoutiana* in 597use *of Hernandia nymphaeifolia* in 561, 597use of *Hernandia voyronii* in 561, 597Maleic anhydride methylvinyl ether copolymer (MAMEC) 844(+)-Malekulatine 584, 566, 590, 594 activity in human cancer cell line 589activity in murine cancer cell line 589as platelet aggregation inhibitor 594circular dichroism (CD) of 584cytotoxic effect of 589diazomethane O-methylation of 584from *Hernandia peltata* 566from *Hernandia sonora* 566from *Hernandia* sp. 594^**1**^ **H**-NMR spectrum of 584 molecular formula of 584O,O-dimethylmalekulatine from 584positive Cotton effects of 584stereochemistry of 584UV spectrum of 584Malignant tumors 841Malonylglucoside 257MAMEC 841 as enzyme carrier 841Mammalian cell 592 carcinogenesis in 592Mammalian lipoxygenases 225Maniladiol 718 structure of 718MAOA 377, 382 deamination of dopamine by 377deamination of serotonin by 377deamination of noradrenaline by 377in fetal brain 377MAO B 377 deamination of dopamine by 377deamination of benzylamine by 378deamination of neurotransmitters by 378deamination of phenylethylamine by 378in adult brain 378MAOA gene 380, 382 aggressive behavior of 380in knockout mice 380Marine polysaccharide (PS) 408 inhibitor of 408Marine sponges 526*Marrubium alysson* 2667-glucoside from 266*Marrubium vulgare* 266 luteolin from 266Marshall\'s synthesis 19--22 of (+)-diseodermolide 19--22Mast cells 367, 370 activity of tryptophan hydroxylase (TPH) in 370Maternal thalidomide 374 autistic features in 374Matrigel-implanted angiogenesis assay 62 activity of triterpenoid fractions in 62Matrigel-induced angiogenesis 67, 69 effect of oleic acid on 69*in vitro* 67*in vivo* 67, 69Matrigel-induced capillary-like tube network 68 effect of oleic acid 68Matrine 205 derivatives of 205structure-activity relationship of 205(+)-Matrine 205 activation of kappa-opioid receptor by 205activity in acid-induced abdominal contraction test 205antinociceptive effect of 205from *Sophora* species 205SAR of 205Maturation 378 serotonin action on 378Maytenfolone-A 643, 644^13^C DEPT NMR data of 643^**1**^ **H** DEPT NMR data of 6432D NOE of 643 from *Celastrus hindsii* 643HMBC of 643MS of 643 structure of 644*Maytenus amazonica* 672, 674, 679 dispermoquinone from 672phenolic triterpenes from 679structure of 674*Maytenus aquifolium* 639 cyclase activity of 639*Maytenus blepharodes* 684 dimeric compounds from 684*Maytenus canariensis* 667 iguesterine from 667*Maytenus dispermus* 6727-oxoquinonemethide dispermoquinone from 672*Maytenus horrida* 666 netzahualcoyene from 666*Maytenus macrocarpa* 657 dammarane triterpenes from 657*Maytenus magellanica* 684 dimeric compounds from 684*Maytenus scutioides* 665, 69215α-hydroxypristimerin from 665, 692*Maytenus* species 693 against *Candida albicans* 693against gram-negative bacteria 693against gram-positive bacteria 693Measles 408 immunization against 408Measles virus (MV) 408, 412Measles virus (MV) replication 408 inhibitor of 408Mechanism 368 of serotonin (5-HT) re-uptake inhibitors 368*MECP2* gene 373 in Rett\'s disorder (RTT) 373mutation in 373Median antinocieptive dose (ED~50~)802Medicinal plants 55 for allergic inflammation 55for arteriosclerosis 55for cancer 55for coronary artery constriction 55for coronary heart diseases 55for diabetes 55for hypertension 55for thrombosis 55for tumor metastasis 55for tumors 55Mediterranean fever 194 use of Δ^6^-tetrahydrocannabinol (THC) 194MEL-28 (human melanoma) 691 phenolic triterpenes against 691Melatonin 369 synthesis of 369role in circadian rhythmicity 369Mental disorders 368 role of serotonin (5-HT) 368*Mentha aevensis* 207 menthol from 207*Mentha haplocalyx* 2 19 neolignans from 219*Mentha lavandulacea* 262 kaempferol 3-O-glucosyl(1→)rhamnoside-7-O-glucoside from 262*Mentha longifolia* 261 isoorientin from 261longitin from 261vicenin-2 from 261*Mentha piperita* 207 menthol from 207Menthol 193, 207 analgesic properties of 207from *Mentha aevensis* 207from *Mentha piperita* 207kappa-opioid receptor activation by 207(-)-Menthol 207 activity in abdominal constriction test 207activity in hot-plate test 207antinociceptive effect of 207*Meretrix petechialis* 400 sulphated β-galactans from 400Merkel cell carcinoma 308 aloe-emodin effects on 308Metabolic pathway 502 of 1α,25(OH)~2~D~3~ 502of 1α,25(OH)~2~D~4~ 502Metabolism 485 of vitamin D analogues 485Metabotropic glutamate receptor 206 interaction of 206Metallo-proteases 836α~2~-macroglobulin inhibition by 836Metaphyta 560 kingdom of genus *Hernandia* 560Metastasis 64 in liver 64in mice 64Metastatic tumor cells 60, 61 in liver 60Metastatic tumor growth 69 in liver 69Metastatic tumors 64 in LLC-bearing mice 64inhibition of 64use of carp oil in 64Methoxybenzene 146, 149Birch reduction of 146 synthesis from 149(R)-3-p-Methoxybenzyloxy-2-methylpropionaldehyde 10 aldol condensation of 1017-(Methoxycarbonyl)-28-nor-isoiguesterine 6676′β-Methoxy-dihydro-scutionin αB 687 ^13^C-NMR spectrum of 6872D NMR of 687HRFAB-MS of 687structure of 687Methoxylated arylpyruvic acids 221 reaction of 221Methoxyphenyl 213 demethylation of 2132-Methoxyphenyl acetones 222 cyclisation of 2222-(2-Methoxyphenyl)1-(methoxyphenyl) ethanone 223 structure of 2232-Methoxyphenylacetones 218 products of 2182-Methoxyphenylpyruvic acid 221 reaction with boron tribromide 2215-Methoxypodophylloton acetate 569 from *Hernandia sonora* 5695-Methoxypodophyllotoxin 569 from *Hernandia sonora* 5695′-Methoxypodorhizol 569 from *Hernandia cordigera* 569from *Hernandia nymphaeifolia* 569from *Hernandia ovigera* 5695′-Methoxypodorhizol acetate 569 from *Hernandia sonora* 5695′-Methoxyyatein 569 from *Hernandia cordigera* 569from *Hernandia ovigera* 569(*S*)-(+)-Methyl 3 -hydroxy-2-methylpropionate 30, 31 role in (-)-pironetin synthesis 30(*S*)-(+)-Methyl 3 -hydroxy-2-methylpropionate 17(+)-discodermolide 17 in synthesis of 17α-Methyl 3-ulosonates 459 stereoselective formation of 459(+)-Methyl 4,6-O-benzylene-α-D-glucopyranoside 30 role in (-)-pironetin synthesis 304-Methyl fentanyl 199 structure of 199α-Methyl ketoside 427 as substrate 4274-Methyl-3,5-bis(3-trifluoromethylphenyl)pent-2-en-3-one 218 isolation of 218Methyltrineracetal 707 structure of 707Mice 27 antitumor activity in 27Microbicidal compound 406 against sexually-transmitted disease agents 406cellulose sulphate 406dextran sulphate 406Microbiological evaluation 739*Micrococcus luteus* 693, 738 antifungal activities against 738minimal inhibitory concentration (MIC) of 693Microorganisms 738 chemical defense against 738Microtubule stabilizing agents 5 discodermolide as 5epothilone as 5eleutherobin as 5laulimalide as 5taxol as 5Microvascular endothelial cells 69Migraine 194, 206, 367, 368 role of serotonin (5-HT) 367, 368use of *Tanacetum parthenium* in 206treatment of 206use of Δ^6^-tetrahydrocannabinol (THC) 194Minimal inhibitory concentration (MIC) 693 of *Bacillus subtilis* 693of *Bacillus pumilus* 693of *Micrococcus luteus* 693of *Staphyllococcus aureus* 693of *Staphyllococcus epidermidis* 693of *Staphyllococcus saprophyticus* 693of *Staphyllococcus warnieri* 693Mitogenesis 4 induction by concanavalin A 4Mitomycin C 691 against hepatoma (HEPA-2B) 691against nasopharynx carcinoma (KB, ED) 691Mitunobu reaction 20, 38Moderate depression 603 treatment of 603Molecular formula 570, 581--584, 586, 587 of (-)-hernone 587of (+)-N-formylovigerine 582of (7R,8S,7′R,8′R)-(+)-7′-acetyl-5′-methoxypicropodophyllin 586of 7-formyldehydroovigerine 581of demethylsonodione 570of ernamymphine 582of herveline A 583of ovihernangerine 584Molluscicidal activity 153, 332, 333 of lapachol 333of natural naphthoquinones 332Monoamine neurotransmitters 627 adhyperforin inhibitor of 627in behavioral models 627Monoamine oxidase (MAO) 377, 384 effect on dopamine 377effect on noradrenaline 377effect on serotonin 377neurotransmitters degradation by 377Monoamine oxidase A (MAOA) 382 genetic variant of 382serotonin degrading enzyme 382Monoamine-synthesis inhibitor 204 inhibition of antinociception by 204Monohydric alkylphenolic acids(anacardic acid-type) 115--116 occurrence of 115structures of 115--116Monohydric phenolic lipids 113--114 occurrence of 113--114structures of 113Mononuclear leukocytes 370 activity of tryptophan hydroxylase (TPH) in 3702-Monooleoylglycerol 104Monosaccharides 279, 447, 451^13^C-NMR spectra of 279 in hemiacetal form 451Monoterpene 569 from genus *Hernandia* 563, 569Monoterpenoids 562 from *Hernandia* sp. 562Monozygotic (MZ) twin 371Moracin 222 as diarylethanoid derivatives 222structure of 222Morbidity 747 in infants 747Morning sickness 561, 597 treatment of 597use of *Hernandia moerenhoutiana* in 561, 597use of *Hernandia nymphaeifolia* in 561, 597use *of Hernandia voyronii* in 561, 597Morphine 193, 195, 200, 801 3-carboxamido analogues of 200as natural analgesic 195from *Papaver somniferum* 193inhibitory effects of 801Morphine analogue 198--200 alfentanil 200bupremorphine 198cyclazosine 198fentanyl 198, 200lofentanil 200sufentanil 200Morphogenic properties 367 of serotonin (5-HT) 367*Morus nigra* 207 use as anti-inflammatory agent 207use in folk medicine 207Morusin 207 antinocicieptive effect of 207Mouse fail-flick assay 815*in vivo* 815Mouse mammary organ culture assay 593 activity of cancer chemopreventive agent 593Mouse mammary organ culture model 591 chemopreventive activity in 591Mouse skin carcinogenesis test 593 activity of cancer chemopreventive agent 593Mouse vas deferens (MVD) 810 activity in receptor binding assay 810mRNA expression 375, 379of serotonin (5-HT)5A receptor 375, 379Mucocutaneous leishmaniasis 742 by *Leishmania braziliensis* 742*Mucor mucedo* 739 antibacterial activity against 739antifungal activity against 739Mukaiyama aldol reaction 17, 42, 43Multi-drug resistant cancers 5 chemotherapeutic agent for 5clinical development for 5Multinucleate syncytia 397Multireference Moller-Plesset theory 542 application of 542mu-opioid receptors 799role in analgesia 799Murine acquired immunodeficiency syndrome (MAIDS) 768Murine cancer cell lines 589, 590 activity of (-)-deoxypodophyllotoxin in 589activity of (-)-hernone in 590activity of (-)-nymphone in 590activity of (-)-yatein in 590activity of (+)-corytuberine in 589activity of (+)-epiaschantin in 590activity of (+)-epimagnolin in 590activity of (+)-epiyangambin in 590activity of (+)-hernovine in 589activity of (+)-laurotetanine in 589activity of (+)-magnoflorine in 589activity of (+)-malekulatine in 590activity of (+)-N-hydroxy-hernangerine in 589activity of *(+)-N-* formylnornantenine in 589activity of (+)-N-formyldehydroovigerine in 589activity of (+)-N-formylovigerine in 589activity of (+)-ovigerine in 590activity of (+)-ovihernangerine in 590activity of (+)-vateamine-2′β-N-oxide in 590activity of 7-formyldehydrohernangerine in 589activity of 7-formyldehydronornantenine in 589activity of 7-formyldehydroovigerine in 589activity of 7-hydroxy-6-methoxy-1-methylisoquinoline in 589activity of 7-oxohernagine in 590activity of demethylsonodione in 589activity of hernandonine in 589activity of hernanymphine in 589activity of *N*-hydroxyovigerine in 589activity of *N*-methylcorydaldine in 589activity of *N*-methylovigerine in 590activity of thalifoline in 590Murine leukemia virus *LP-BM5 MuLV* 768 cause of immunodeficiency syrdrome 768Mutagenesis 174 induction by xenobiotics 174Mutagenic activity 750 in Ames test 750Mutation 377 in autistic children 377MVD assay 801 *in vitro* model 801δ opioid activity in 801MVD bioassay 807, 818 \[Tic^2^\]deltorphin C activity in 807activity of \[Tic^2^\]deltorphin C in 818*in vitro* 807, 818*Mycobacterium leprae* 119 leprosols from 119resorcinolic lipids derivatives from 119Myeloid leukemia cells differentiation 498 effect of 1α,25-dihydroxyvitaminD~3~ 498Myles\'s synthesis 10--12 of discodermolide 10--12Myristic acid 65 from carp oil 65*Mytenus macrocarpa* 659 dammarane triterpenes from 659Myxovirus 408 inhibitor of 408
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N-N**-methylcarbamoyl)**-O-methylbulbocapnine 564 from genus *Hernandia* 563from *Hernandia nymphaeifolia* 564*N*-Acetylmannosamine 425 irreversible condensation of 425*N*-Acetylneuraminic (Neu5Ac) aldolase 424 structure of 424*N*-Acetylneuraminic (Neu5Ac) synthetase 424 structure of 424*N*-Acetylneuraminic acid (Neu5Ac) 420, 425 catalyzed by Neu5Ac synthetase 425synthesis of 425Nactrexone 2003-carboxamido analogues of 200Naloxone 802, 804, 815 effect of 815Naltrindole 816 antinociceptive action of816(+)-Nandigerine (hernangerine) 565 from *Hernandia cordigera* 565from *Hernandia guianensis* 565from *Hernandia nymphaeifolia* 565from *Hernandia ovigera* 565from *Hernandia ovigera* var. *mascarenensis* 565Nantrindole 803, 804, 806 as δ-opioid receptor antagonist 803blockade of δ-opioid receptors by 802**derivatives** of 806 effects of 804Naphtharazin 326 structure of 326Naphthoquinones 320 redox capacity of 3201-Naphthylacetone 218 brominated product of 218Naphtodianthrones 607 from genus *Hypericum* 607Narcotic 200 fentanyl as 200Narcotic analgesic effect 200Narcotic opiate alkaloid 80413-Narin-II8--4′-Ome-eridictyol 207 activity in formalin test 207activity in writhing test 207Natural analgesic products 195 capsaicin as 195Δ^9^-tetrahydrocannabinol as 195 morphine as 195Natural flavonol 224 antioxidant properties of 224kaemferol from 224Natural inhibitors 591 of carcinogenesis 591Natural naphthoquinone 332 from *Lawsonia alba* Lam. 332Natural opioid peptides 799 discovery of 799Natural polyphenols 226 activity in biochemical assays 226effect on HIV-1 integrase inhibition 226Natural products 55, 79, 191, 219, 703, 738 antitumor effect of 55, 56as analgesics 191as anti-obesity 79defensive role of 738effects of 79from plants 703in allergic inflammation 55in arteriosclerosis 55in cancer 55in coronary heart diseases 55in diabetes 55in heart diseases 55in hypertension 55in thrombosis 55in tumor metasiasis 55use of 191vascular physiological effect of 55Natural steroid 504, 505 ergosterol 505sitosterol 505stigmasterol 505synthesis of 504Natural steroids synthesis 504 of vitamin D analogues 504Natural therapeutic herb 194 as analgesic 194*Cannabis sativa* L. as 194 n-butyrate 592as EBV inducer 592Negishi coupling reaction 13Neochromes 530, 547 formation of 547Neolignans 219 biosynthesis of 219from *Mentha haplocalyx* 219from *Salvia officinalis* 219structure of 219(+)-Neolitsine 565 from *Hernandia cordigera* 565Neoxanthin 530*Nepeta* flavonoids 268*Nepeta hindostana* 268 nepitrin from 268Nepetin 749 structure of 749Nerolidol 715, 722, 724 from *Baccharis dracunculifolia* D. 715structure of 722Nerve growth factor (NGF) 504 role in development of neurons 504Netzahualcoyene 666, 667 from *Maytenus horrida* 666Neu5Ac 425, 440, 445--448, 460, 463, 468 approach to 468biosynthesis of 425from non-carbohydrate precursor 460Grignard reaction of 445--448 preparation of 440, 463role of *N*-acetyl-D-mannosamine in 425role of phosphoenolpyruvate 425synthesis of 445--448total synthesis of 460Neu5Ac aldolase 425, 426 by Aldol reaction 425from bacteria 425*in vivo* 425 isolation of 425mammals 425use of 426Neu5Ac aldolase catalysis 428 synthesis of KDO by 428Neu5Ac analogs 426 preparation of 426Neu5Ac precursor 461 and stereospecific hydroxylation 461Neu5CBz 426Neuralgia 203 use of ginseng root in 203Neuraminic acid 420 deaminated form of 420Neuraminic acid derivative 440Neurite outgrowth activity 505 in hypothalamic neurons of rat 505in neurons 505of dictyosterol 505of natural product 505Neurochemical pathway 374 of autistic spectrum disorders 374Neurodegeneration 224 role of free radicals in 224Neurogenic pain 205 induction by formalin 205inhibition by incarvillateine 204Neurokinin NK, receptor 203 interaction with ginseng 203Neuronal activity 376 in amygdala 376role of human serotonin transporter gene (SLC6A4) in 376Neuronal differentiation 368 effect of serotonergic neurotransmission on 368Neuronal excitability 194 role of cannabinoids 194Neuronal functioning 378 serotonin action on 378Neurons 367Neuropathological studies 376 in autistic brains 376Neuropatic pain syndromes 193 use of capsaicin in 193Neuropeptide 193 depletion of 193*Neurospora sp.* 528 neurosporaxanthin from 528Neurosporaxanthin 528, 529 from *Neurospora sp.* 528properties of 529Neurosporaxathin 517 structure of 517Neurotransmitter 367 serotonin as 367Neurotransmitter degradation 377 by monoamine oxidase (MAO) 377Neurotropic factors (NTFs) 504 in maintenance of nerve cells 504role in survival of nerve cells 504Neutral carotenoids 537 oxidation potential of 537Neutral lipid 788Nevenone 151 from *Navanax inermis* 151(+)-N-formyldehydroovigerine 563, 589 activity in human cancer cell line 589activity in murine cancer cell line 589cytotoxic effect of 589from genus *Hernandia* 563from *Hernandia sonora* 563N-formylnomantenine 563 from genus *Hernandia* 563from *Hernandia sonora* 563(+)-N-formylnornantenine 563, 589 activity in human cancer cell line 589activity in murine cancer cell line 589cytotoxic effect of 589from genus *Hernandia* 563from *Hernandia sonora* 563(+)-N-formylovigerine 563, 582, 589 activity in human cancer cell line 589activity in murine cancer cell line 589cytotoxic effect of 589from genus *Hernandia* 563from *Hernandia sonora* 563^**1**^ **H**-NMR spectrum of 582HREIMS of 582IR spectrum of 582LREIMS of 582 molecular formula of 582NOESY experiment of 582UV absorption of 582**NF-kB** activation 206 effect of parthenolide 206N-glycoylneuraminic 427 synthesis of 427NHAc 421 structure of 421NHAc (Neu5Ac) 421 structure of 421(+)-N-hydroxyhernangerine 564, 589 activity in human cancer cell line 589activity in murine cancer cell line 589cytotoxic effect of 589from genus *Hernandia* 563from *Hernandia nymphaeifolia* 564N-hydroxyovigerine 564, 589 activity in human cancer cell line 589activity in murine cancer cell line 589cytotoxic effect of 589from genus *Hernandia* 563from *Hernandia nymphaeifolia* 564NIR absorption spectra 549 of canthaxanthin 549of lycopene 549of phytoene 549of radical anions 549of β-carotene 549Nitrogen Kagan\'s ether analogue 2163,4-dihydroxyphenylserine as 216(+)-N-methyl-6,7-dimethoxyisoquinolone 564 from genus *Hernandia* 563from *Hernandia sonora* 564(+)-N-methylactinodaphnine 564 from genus *Hernandia* 563*Hernandia cordigera* from 564N-methylcorydaldine 564, 589 from genus *Hernandia* 563from *Hernandia nymphaeifolia* 564from *Hernandia ovigera* 564N-methylhernangerine 565, 594 as platelet aggregation inhibitor 594from *Hernandia sonora* 565from *Hernandia* sp. 594(+)-N-methylhernangerine 590 activity in human cancer cell line 589activity in murine cancer cell line 589cytotoxic effect of 589N-methylhernovine 565 from *Hernandia guianensis* 565from *Hernandia nymphaeifolia* 565(+)-N-methyllaurotetanine 565 from *Hernandia nymphaeifolia* 565from *Hernandia voyronii* 565from *Hernandia cordigera* 565N-methylnandigerine 565 from *Hernandia guianensis* 565from *Hernandia ovigera* var.*mascarenensis* 565(+)-N-methylovigerine 565 from *Hernandia nymphaeifolia* 565N-methylovigerine 590 activity in human cancer cell line 589activity in murine cancer cell line 589cytotoxic effect of 589NMR 550 application of 550NMR signals 587 of (-)-hernone 587NMR spectra 718 of Baccharis oxide 718Nociception 191, 193, 205 by chemical noxious stimuli 191role of endogenous peptide opioids 193thermal model of 205Nociceptive threshold 802 of mice 802Nociceptors 191, 193 activation of 193in periphery 193NOESY experiment 582 of (+)-N-formylovigerine 582NOESY interactions 587 of (-)-6′-hydroxyyatein 587of (-)-hernone 587Non-enveloped viruses 627 adenovirus 627poliovirus 627Nonaene chromophore 526Non-classical cannabionoids 195, 197, 198 group of cannabinoid receptor ligands 197Non-steroidal anti-inflammatory drugs (NSAIDs) 192, 744, 752 clinical use of 192use in dental surgery 192use in headache 192use in osteoarthritis 192use in rheumatism 192Non-tumorigenic 593JB6 precursor cells as 593Nonulosonic acids 421Nonulosonic acid analogues 426 formation of 426role of hexoses 4262-Nonulosonic acid derivatives 467Noradrenaline 192, 204, 377, 627, 787 as hyperforin inhibitor 627effect of monoamine oxidase (MAO) 377inhibition of hypotensive effect of 787re-uptake inhibition by DPHD 204Noradrenaline release 787 from sympathetic nerve fibers 787Noradrenaline-induced lipolysis 83 activation by caffeine 83Nor-carotenoids 516(+)-Norisocorydine 565 from *Hernandia cordigera* 565from *Hernandia voyronii* 565nor-Isoiguesterin 694Norlignans 222 as diarylethanoid derivatives 222structure of 222(+)-Nornantenine 565 from *Hernandia cordigera* 565from *Hernandia nymphaeifolia* 565Norpredicentrine 565 from *Hernandia voyronii* 565Norsonodione 565 from *Hernandia sonora* 565(+)-6-Northalicarpine 566 from *Hernandia peltata* 566Northalifoline 565 from *Hernandia nymphaeifolia* 565Norysca 609, 610*Nothogenia fastigiata* 403, 408 anti-influenza activity of 408xylomannans from 403Novel analgesics 206 target of 206Novel gallic acid derivatives 208 design of 208Novoimanine 628 antimicrobial activity 628Noxious stimuli 192 sensitisation of 192Nozaki-Hiyama reaction 24Nozaki-Kishi coupling reaction 8, 10, 11NSAIDs (classical) 192 effects on COX enzymes 192side effects of 192N-substituted NeuAc derivatives 427 preparation of 427N-tosylated phenylalanine derivatives 216 conversion of 216Nuclear Overhauer enahncement (NOE) 581N-unprotected Neu5Ac 427 preparation of 427N-vanillyl-N-(3-acyloxy-2-benzylpropyl)-thioureas 201 as vallinoids 201Nymphaeol A 567 from *Hernandia nymphaeifolia* 567Nymphaeol B 567 from *Hernandia nymphaeifolia* 567Nymphaeol C 567 from *Hernandia nymphaeifolia* 567(-)-Nymphone 569, 590 activity in human cancer cell line 589activity in murine cancer cell line 589cytotoxic effect of 589from *Hernandia nymphaeifolia* 569O,O-dimethylmalekulatine 584 from (+)-malekulatine 584
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O,O-dipropylphosphoroselenoic acid ester 529*Origanum compactum* 269 pyranosyl flavone from 269Obesity 79, 80, 83 role of oolong tea 80use of orlistat (Ro 18--0647)83Obsessive compulsive disorder 368, 369 effect of circadian activity on 369role of serotonin (5-HT) 368Occupational asthma 337 carmine use for 337*Ocimum americanum* var. *pilosum* 256 vicenin-2 from 256*Ocimum grandiflorum* 256 isothymusin from 256Ocobotrine 565 from *Hernandia voyronii* 565*Octolasion tyrtaeum* 828 from *Lumbricidae* family 828*Octolasium lacteum* 828 from *Lumbricidae* family 828Octulosonic acid 421Octulosonic bicyclic precursors 473 synthesis of 473O-Glycosylation 814 role in δ receptor affinity 814role in δ receptor affinity 8145-OH tryptophan decarboxylase 3701α,25(OH)~2~D analogue 497 in human osteosarcoma 4971α,25(OH)~2~D~2~ 494, 495 binding affinity of 494bone resorbing activity of 495calcemic effect of 4951α,25(OH)~2~D~3~ 484, 494, 495, 500 analogues of 484binding affinity of 494bone resorbing activity of 495calcemic activity of 484, 495effect on bone maturation 484effect on calcium metabolism regulation 484effect on immune responsiveness 484effect on malignant cell differentiation 484in multifunctional biological responses 484pharmacokinetics parameters of 500use in cancers 484use in immune disorders 484use in psoriasis 4841, 25(OH)~2~D~3~ calf thymus receptor 496 competitive binding to 4961α,25(OH)~2~D~3~ metabolites 4951α,25(OH)~2~D~4~ 495, 499, 500, 501, 504 bone resorbing activity of 495calcemic effect of 495effect on animal model with osteoporosis 499in rat 504metabolic pathway of 504pharmacokinetics parameters of 500synthesis of 5011α,25(OH)~2~D~4~ activity 497 affinity of 497bone mobilization of 497on calcium transport 4971α,25(OH)~2~D~4~ drug 503 for immune disorders 503for osteoporosis 503for skin diseases 5039-nor-9-OH-hexahydrocannobinol (HHC) 195, 196 analgesic activity of 195structure of 197type of non-classical cannabionoid 197Oleanolic acid 697, 718, 719*Baccharis linearis* 7 19*Baccharis rhomboidalis* J. 719*Baccharis solieri* D.C. 719 role in liver disorders 637role in liver injury 637structure of 718Olefin 43 oxidative cleavage of 43Oleic acid 56, 64, 65, 66, 68, 69 antitumor activity of 56effect on DNA synthesis in LLCcells 68effect on liver metastatic tumor colonies 66effect on matrigel-induced capillary-like tube network 68effect on spleen weight 66from carp oil 65inhibition of tumor growth by 64inhibitory actions of 69Matrigel-induced angiogenesis*(in vivo)* 69OLR-1194 as endogenous peptide opioids 193Olvanil 193, 202 analgesic action of 193as anti-inflammatory substances 201as capsaicin congener 201as vanilloid receptor agonists 202for analgesia 201phamacological profile of 201role in vasorelaxation 201structures of 202O-methylbaccharocephol 716 structure of 716*Oneostemon bojerianum* 1395-alkylresorcinols from 139Oolong tea 80, 82 classification of 80effect on body weight 82effects of 82*Ophiorrhiza pumila* 344 anthraquinones from 344Opioid 799, 800 pharmacodynamics of 799pharmacokinetics of 799physiochemical properties of 800transportation from blood-brain barrier (BBB) 800δ-Opioid activity 801 in MVD assay 801Opioid agonist 813Opioid analogues 800, 813 analgesic potencies of 800development of 813permeation of 800structure activity relationship studies (SAR) of 800δ-Opioid antagonist 813 activity of 813Opioid dipeptide δ-antagonist 808 physiochemical properties of 809Opioid drug effects 203 of ginsenosides 203inhibition by ginseng extracts 203Opioid interaction 807 with κ-receptors 807Opioid peptides 799, 814 classes of 799, 814from *Phyllomedusa* amphibians 799, 814Opioid receptivity 808 of ligands 808δ-Opioid receptor 205, 801, 802, 804, 814 activity in guinea-pig ileum bioassay 802affinity of 802binding affinities of 205binding sites of 814*in vitro* bioassay of 804 interaction with 804pharmacological bioassay of 801radioligand binding assay of 801δ Opioid receptor 193, 802, 814 as endogenous peptide opioids193 binding sites of 814 blocked by naltrindole 802Opioid receptor affinities 814 of glycopeptides 814determination of 814δ-Opioid receptor antagonist 204, 803, 804H-Dmt-Tic-Ala-OH (DTA) as 804 inhibition of antinociception by 204κ-Opioid receptor antagonist 204 inhibition of antinociception by 204δ-Opioid receptor antagonist 204 inhibition of antinociception by 204Opioid receptor binding 812 of pentapeptides 812Opioid receptor complex 194δ-Opioid receptor ligand 817Opioid receptor subtypes 800 delta 1800delta 2800Opioid receptors 200 binding of 200ligands for 200δ-Opioid receptors affinity 817*in vitro* 817 pharmacological assay (guinea-pig ileum) for 817δ-Opioid receptors affinity 817*in vitro* 817 pharmacological assay (guinea-pig ileum) for 817Opioid system 799 dynorphins in 799endorphins in 799enkephalins in 799in central nervous system (CNS) 799in peripheral tissues 799ligands of 799physiological functions of 799receptor types (δ,δ,κ)799Opioid tripeptide δ-antagonist 808 physiochemical properties of 809Opioids 193, 194, 799 as analgesic 799as anti-nociceptive 193in neurotransmitter system 799side effects of 194Opportunistic *Listeria* infection 773 in immunodeficient mice 773O-Quinonic 169 formation of 169for allergy induction 169Oroxylin A 288 structure of 288Osteoarthritic cartilage 318Osteoarthritis 192 use of inflammatory drugs (NSAIDs) 192use of prostaglandin inhibitors 192Osteoarthritis pathophysiology 318 interleukin-1 β role in 31812-O-tetradecanoylphorbol 13-acetate (TPA) 592, 593, 695 as tumor-promotion agent 592*in vitro* bioassays of 592 inhibition of 695role in tumor-promotion 593Ovarian tumor 5, 27 clinical development for 5chemotherapeutic agent for 5effect of pironetin derivatives in 27inhibitors of tubulin 27Ovigeridimerine 566 from *Hernandia nymphaeifolia* 566(+)-Ovigerine 565, 590, 594 activity in human cancer cell line 589activity in murine cancer cell line 589as platelet aggregation inhibitor 594cytotoxic effect of 589from *Hernandia cordigera* 565from *Hernandia guianensis* 565from *Hernandia nymphaeifolia* 565from *Hernandia ovigera* 565from *Hernandia sonora* 565from *Hernandia* sp. 594Ovihernangerine 566, 584 by HREIMS of 584EIMS of 584 from Genus *hernandia* 566from *Hernandia nymphaeifolia* 566IR spectrum of 584 molecular formula of 584UV spectrum of 584(+)-Ovihernangerine 590 activity in human cancer cell line 589activity in murine cancer cell line 589cytotoxic effect of 589Oviisocorydine 567 from *Hernandia nymphaeifolia* 567Oxalacetic acid 433, 435 as pyruvate equivalent 433reaction of 433Oxepahyperforin 613 structure of 613Oxidation 17, 473, 506, 627 of aldehyde 473of hyperforin 627of PMB group 17Oxidative cleavage 8 of p-methoxybenzyl (PMB) ether 8Oxidative hydrolysis 438 formation of 438of dithioacetal moiety 438of KDO derivative 438Oxidative mutagens 317 naphthoquinones as 317Oxirane ring opening 46324-(E)-3-Oxo-dammara-20, 24-dien-26-al 657 from *Rapanea umbellate* 657^**1**^ **H**-NMR spectrum of 657IR spectrum of 6575--2-Oxoalkylresorcinol 149 in *Cereale secale* 149Oxocrebanine 565 from *Hernandia ovigera* 5657-Oxohernagine 565, 590, 595 activity in human cancer cell line 589activity in murine cancer cell line 589as platelet aggregation inhibitor 594cytotoxic effect of 589from *Hernandia nymphaeifolia* 565from *Hernandia* sp. 594Oxohernandaline 565 from *Hernandia nymphaeifolia* 5657-Oxohernangerine 565 from *Hernandia nymphaeifolia* 565Oxonantenine 566 from *Hernandia nymphaeifolia* 5662-Oxopropyl glycosides 4557-Oxoquinonemethide dispermoquinone 672 structure of 672Oxothalicarpine 567 from *Hernandia ovigera* 569Ozonolysis 486, 489 in steroid moiety synthesis 486of ergosterol 489
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P substance 193 as pro-nociceptive 193P-388 (mouse lymphoma) 691 phenolic triterpenes against 691P-388 (murine lymphocytic leukemia) 588 activity of (-)-deoxypodophyllotoxin against 588activity of (-)-yatein against 588P450-dependent biotransformation 316 of chrysophanol 316of emodin 316PAF 594 antiplatelet activity of 594Paicalein 70Pain 191, 194, 203 control of 194sensory component of 191use of ginseng root in 203with cannabinoids 194Pain disorders treatment 192 by COX-2 inhibitor 192Pain mechanisms 191Pain mediator 192 cytokines as 192glutamate as 192histamine as 192leukotrienes as 192noradrenaline as 192prostaglandins as 192substance P as 192Pain sensation 201Pain transmission 194Palladium coupling reaction 12Palladium-catalyzed coupling reaction 8 of vinyl iodide 8Palladium-catalyzed cross-coupling reaction 17(-)-Pallidine 566 from *Hernandia voyronii* 566Palmitic acid 65, 104 from carp oil 65*Panax ginseng* 344 suspension cultures of 344Pancreatic enterochromaffin cells 370 activity of tryptophan hydroxylase (TPH) in 370Pancreatic lipase 82, 84*in vitro* 84 inhibitory assay for 82Pancreatic lipase activity 79, 88, 89, 90, 94, 108 effect of *platycodi radix* on 79, 88effect on 94effects of inulin extracts on 90effects of *platycodi radix* extracton 90*in vitro* 88, 90, 94 inhibiton of 79, 108role of chitin-chitosan 79role of chondroitin sulfate 79role of *platycodi radix* saponin 79role of tea saponin 79Pancreatic lipase activity inhibition 86 by oolong tea 86Pancreatic lipase inhibitor 83 orlistat (Ro 18--0647) as 83Panic disorder 368, 369 effect of circadian activity on 369role of serotonin (5-HT) 368*Papaver somniferum* 193 as analgesic 193codeine from 193morphine from 193papaverine from 193thebaine from 193Papaverine 193 from *Papaver somniferum* 193Papillomavirus 405, 394 cause of cancer 394cause of papillomas 394members of 405Papuaforins *(p)A-E* 617 structure of 617Parachlorophenylalanine 378 serotonin synthesis inhibitor 378Paramyxovirus 408Parasitemia 596, 694 induction by *Plasmodium yoelii*N67 cell line 596Parasitemia inhibitor 597*in vivo* 597Parthenolide 206 antinociceptive effects of 206as anti-inflammatory 206effect on NF-κB activation 206Parvoviruses 394Passive immunization 406 with hyperimmune globulin 406Paterson\'s synthesis 22--26 of discodermelide 22--26Pathogenic bacteria 421*Legionella pneumophila* 421*Pseudomonas aeruginosa* 421*Shigella boydi* 421Pathological anxiety 376 role of serotonin (5-HT) in 376Pathophysiological inflammatory reactions 744Pavinan alkaloids 217Pavine-benzyltetrahydro-isoquinoline dimer 583Paw oederma 207 inhibition of 207PCDF congeners 764 fecal excretion of 764Pectolinaringenin 725, 748 antispasmodic activity of 748structure of 725*Pelargonium xhortorum* 146 for pest resistance 146Penduletin 726 structure of 726Penicillin 738Pentaacetyl gluconic acid 450Pentacyclic triterpenes 207 protein kinases inhibition by 2073-Pentanone 10 aldol condensation of 10Pentobarbital 62Pentosan polysulphate 412Pentosan sulphate 397 in HIV therapy 397Pentoses 430 as substrates 430Peptidoleukotrienes 225 type of leukotrienes 225Peridiain 522 structure of 522(+)-Perillaldehyde 569 from *Hernandia voyronii* 569Peripheral nervous system 194 cannabinoid receptors in 194Peripheral tissues 799 opioid system in 799Permeability 171 of liposomal membranes 171Permeation 800 of opioid analogues 800Per-O-acetyl pyranosyl bromides 453 reaction of 453Pervasive development disorder (PDDs) 372, 384 asperger\'s syndrome (AS) 372autistic disorder (AD) 372childhood disintegrative disorder (CDD) 372effect on social skills in 372group of 372Rett\'s disorder (RTT) 372Pervasive development disorder (PDDs) 372Pervasive development disorder-not otherwise specified (PDD-NOS) 384Pharmacodynamic properties 799 of opioid 799Pharmacokinetic properties 799 of opioid 799Pharmacokinetic studies 811, 818 of di (DTOH) 811, 818of tripeptide (DTAOH) 811, 818Pharmacokinetic trials 592Pharmacokinetic parameters 501 of 1α,25(OH)~2~D~3~ 501of 1α,25(OH)~2~D~4~ 501Pharmacokinetic study 500 of 1α,25(OH)~2~D analogue 500Pharmacological actions 55 of natural products 55Pharmacological activity 287, 603, 797, 813 of δ receptor agonists 797of δ receptor antagonists 797of δ receptor agonists 797of δ receptor antagonists 797of κ receptor agonists 797of κ receptor antagonists 797of acylphloroglucinols (hyperforins) 603of biflavones 603of deltorphin C 813of dermorphin 813of D-glucopyranosyl moiety 813of flavonoids 287of flavonol glycosides (quercetin) 603of Labiatae family 287of metabolites 603of naphtodianthrones (hypericins) 603Pharmacological approaches 55Pharmacological bioassay 801 of δ opioid receptor 801of δ opioid receptor 801Pharmacological profiles 762 of *Chlorella* 762of green algae 762Pharmacological properties 843 of earthworm fibronolytic enzymes (EFEs) 843Pharmacological studies 304 of quinones 303Pharmacologically active polymers 395Pharmacophore 196, 198 of 3-alkyl-5-arylimidazolidinediones 198Phenolic lipids 111, 139, 150--176 as modulators of lipid oxidation 172--176 bioactive-111biological properties of 150--176occurrence of 111separation of 139structural elucidation of 139synthesis of 139--150Phenolic triterpenes 674, 679, 691 against HT-29 (human colon carcinoma) 691against MEL-28 (human melanoma) 691against P-388 (mouse lymphoma) 691against Δ-549 (human lung carcinoma) 691from *Maytenus amazonica* 679Phenols 724 as antioxidants 724as aromatizers 724as colouring agents 724as flavourings agents 724as secondary metabolites 724in the food industry 724pharmaceutical interest 724Phenyl sulfone derivative 486 dehydration of 486hydrogenation of 486synthesis of 486Phenylephrine-induced vasoconstriction 72, 73, 75 effect of nitric oxide (NO) synthetase 73effect of xanthoangelol 74effect of xanthoangelol E 74Phenylethanal 215 reaction of 215Phenylketonuria 374 autistic features in 374Phenyllactic acid 216 converstion of 216rearrangement of 2162-Phenylnaphthalene 214C-condensation of 214 from arylethanals 214mechanism of formation of 2142-Phenylnaphthalene derivatives 216 from marine sponge *Jaspis* sp. 216Phenylserine 216 conversion of 216Phenylsulfone derivatives 488 synthesis of 488*Phlomis aurea* 265 apigenin 7-glucoside from 265*Phlomis spectabilis* 265Phlomisflavoside A 294 structure of 294Phlomisflavoside B 294 structure of 294Phloroglucinol 629 against *Staphyllococcus aureus* 629Phloroglucinol derivatives 629 antimicrobial activity of 629Phloroglucinols 610, 629 antimicrobial activity 629Phorbol esters 593 in tumor-promotion 593Phorbol myristate acetate (PMA) 70Phosphatidylcholine 79, 103Phosphoelnolpyruvate-dependent aldolases 424 structure of 424Phosphoenolpyruvate 423 synthesis of 423Phosphoenolpyruvate (PEP) 423, 429, 425 irreversible aldol reaction of 429irreversible condensation of 425Phosphorylation 808 of G-coupled proteins 808Photocytotoxic action 315 of hypericin 315Photodermatosis 607 of hypericism 607Photodynamic therapy 315*in vivo* 315Photoinduced electron transfer 540 in β-carotene 540in canthaxanthin 540Photooxidation 443 role in aldol reaction 443Photosensitizers 607 hypericism as 607Photosynthesis 521, 762Photosystem 537 cation radicals in 537Phototrophic bacteria 521, 522 p-Hydroquinone 567from *Hernandia ovigera* 567p-Hydroxyacetophenones 731structure of 731*Phyllanthus* genus 207, 208 analgesic effect of 208in treatment of hepatitis 207use in kidney disturbances 207use in urinary lithiasis 207used in folk medicine 207*Phyllomedusa* amphibians 799, 814 opioid peptides from 799, 814Phylloquinone 304 as primary metabolites 304Physiological effects 192 of COX-1 enzyme 192Physiological function 637, 799 of opioid system 799of triterpenes 637Physiological mechanism 367 of serotonin 367Phytopolysaccharide (PS) 401 inhibitors of 401Phytochemical studies 603 of *Hypericum* 603Phytoene 519 structure of 519Phytofluene 519 structure of 519Phytotherapeutic preparations 703 from plants 703Phytotoxins 751 toxic effects of 751Picornavirus 406Picropodophyllin 569 from *Hernandia guianensis* 569from *Hernandia sonora* 569Pictet-Spengler cyclisation 216Pimagnolin 592 as EBV inhibitor 592Pineal hormone 369 melatonin as 369Pinobanksin 729 structure of 729Pinocembrin 728 structure of 728*Pinus parviflora* 407 acidic polysaccharide from 407Piperidine alkaloid hydrochloride 204 antinociceptive action of 204from *Siphocampylus verticillatus* 204Pironetin 3, 26--46(5R,6R)-5-ethyl-5,6-dihydro-6\[(E)-(2R,3S,4R,5S)-2-hydroxy-4-methoxy-3,5-dimethy1--7-nonenyl\]-2H-pyran-2-one 29^13^C NMR of 29^**1**^ **H** NMR of 29 against transplanted murine tumor cell lines P 388 leukemia 27antitumor activity of 27, 28as antitumor agent 3as immunosuppressive agnet 3as plant growth regulator 26biological activity of 26biosynthesis of 26, 29Chida\'s synthesis of 38--40COLOC of 29COSY of 29DEPT of 29Dias synthesis of 44--46 effect on 3Y1 cell 27effect on cell cycle progression 27effect on DNA content 27effect on M-phase 27from *Streptomyces* sp. 26Gurjar\'s syntheses of 33--37 immunosuppressive effect of 26*in vivo* 28IR of 29 isolation of 26Kawada\'s synthesis of 30--33Keck\'s synthesis of 42--44Kitahara\'s synthesis of 40--42 structure elucidation of 26structure of 27structure of 3synthetic routes to 3, 30X-ray crystallographic analyses of 29Pironetin derivatives 27 effect on uterine tumor 27effect on ovarian tumor 27PKC activation 71 inhibition of 71Placenta 561 role of *Hernandia moerenhoutiana*in 561role of *Hernandia nymphaeifolia*in 561role *of Hernandia voyronii* in 561Plamitoleic acid 65 from carp oil 65Plasma triacylglycerol concentration 89 effect of *Platycodi radix* on 89Plasmin 830, 838Plasmin-activator 839EFE as 839Plasminogen (PLg) 843, 838α-Plasminogen activator 841G-90 as 841Plasminogen activator (e-PA) 826 from *Eisenia fetida* 827Plasminogen activator inhibitor (PAI) 844Plasminogen inhibitors 841 from *Eisenia fetida* 841role in tissue protection 841Plasminogen-free fibrin plates 833Plasminogen-rich fibrin plates 833*Plasmodium* strains 694 against human adenocarcinoma cell line HT-29694Platelet 593 role in hemostatic process 593Platelet activating factor (PAF) 594 platelet aggregation induced by 594Platelet activation 70 role of serine protease in 70role of thrombin in 70Platelet aggregation 593, 594, 838 arterial thrombosis due to 593collagen induction by platelet activating factor (PAF) 594induction by arachidonic acid 594induction by thrombin 594Platelet aggregation inhibitor 594(-)-deoxypodophyllotoxin as 595(-)-hernone as 595(-)-yatein as 595(+)-epiaschantin as 595(+)-epimagnolin as 595(+)-epiyangambin as 595(+)-hernandaline as 594(+)-laurotetanine as 594(+)-malekulatine as 594(+)-ovigerine as 594(+)-reticuline as 595(+)-thalicarpine as 595(+)-vateamine-2′β-N-oxide as 5957-oxohernagine as 595 dehydrohernandaline as 594*Hernandia* species as 594 hernangerine as 594isoquinoline alkaloids as 594isovanillin as 594lignans as 594N-methylhernangerine as 594Platelet serotonin (5-HT) 380 in autistic patients 380*Platycodi radix* 89, 91 effects on liver triacylglycerol 89effects on liver weight 89effects on plasma triacylglycerol level 90effects on total cholesterol 89PMA-thrombin 70 inhibition of 70p-methoxybenzyl (PMB) ether 8oxidative cleavage of 8p-nitroanilide 834hydrolysis of 834Pocine pancreatic elastase (PPE) 830, 831, 843 homologous sequences of 831Podophyllotoxin 569 from *Hernandia ovigera* 569rom *Hernandia sonora* 569Podorhizol 569, 592 as EBV inhibitor 592from *Hernandia cordigera* 569from *Hernandia guianensis* 569from *Hernandia ovigera* 569Poliomyelitis 394, 411 transmission of 411vaccination against 411Polio virus 411, 743 replication of 411, 743use of antivirals 411Polio virus type 1743 antiviral activity of 743Polio virus type 3 326 aloe-emodin against 326Polychlorinated dibenzofuran (PCDF) congeners 763 in rats 763Polychlorinated dibenzo-p-dioxin (PCDD) 763 of fecal excretion 763Polychlorinated dibenzo-p-dioxin (PCDD) congeners 763Polygodial 193, 206 antinociceptive action of 206from *Ginger* species 193Polygodial 206 effect on TRPVI 206*Polygonum cuspidatum* 340 anthraquinone emodin from 340Polyhydroxylated 2-phenylnaphthalenes 225 effect on 5-lipoxygenase inhibition 225Polymerase chain reaction (PCR) 384, 843Polyphenols 224, 226, 227 anti-HIV activity of 226antiinflammatory activity of 224antimitotic activity of 224anti-tumor activity of 224antiviral activity of 224as anti-HIV agents 227biological activities of 224Polysaccharidic molecule 395 as virus inhibitor 395Porcine HSV 404 in epizootic infections 404Positive Cotton effects 584 of (+)-malekulatine 584Positron emission tomography (PET) 377, 384Postpartum hemorrhage 561, 597 treatment of 597use of *Hernandia moerenhoutiana*in 561, 597use of *Hernandia nymphaeifolia*in 561, 597use *of Hernandia voyronii* in 561, 597Post-transcriptional modifications 384 of RNA 384Potato viruses 412 antiviral activity againt 412Prader-Willi/Angelman syndrome 374Prenylated coumaric acids 730 structure of 730Prenylflavonoid 207 antinocicieptive effect of 207Presynaptic neuron 381 serotonin (5-HT) in 381Previtamin D derivatives 486 thermal isomerization of 486Primary solid-tumor growth 64 effect of triterpenoids on 64Pristimarin 692 cytotoxic activity of 692*Pristimeria indica* 664 celastrol from 664pristimerin from 664Pristimerin 664 from *Tripterygium wilfordii* 664from *Celastrus scandens* 664from *Pristimeria indica* 664structure of 664Pro-inflammatory substances 206 in chronic painful inflammatory diseases 206Proliferation 368, 378 effect of serotonergic neurotransmission on 368serotonin action on 378Pro-nociceptive prostaglandins 192 in inflammation 192Pro-nociceptive transmitter 194 release inhibition of 194Prooxidant activities 745 in thiobarbituric acid assays 745of chemiluminescence 745of tert-butyl hydroperoxide 745Prooxidant property 524 of carotenoids 524Prophylactic drugs 407Propiophenone derivative 731 structure of 731Prostaglandin inhibitors 192 clinical use of 192use in rheumatism 192use in osteoarthritis 192use in headache 192use in dental surgery 192Prostaglandins 192 as pain mediator 192in mast cells 192nociceptive effect of 192Prostanoids 192 formation of 192from arachidonic acid 192Prostate cancer prevention 525 role of lycopene in 525Protease 226, 831 chymotrypsin 831earthworm chymotrypsinogen 831F-III-1(2)831 human leukocyte elastase (HLE) 831lugworm chymotrypsinogen 831pocine pancreatic elastase (PPE) 831role in HIV 226trypsin 831U(t)-PA, plasmin 831Protection-deprotection reaction 461Protein kinase A (PKA) 192 in regulation of ionotropic receptors 192Protein kinase C (PKC) activator 70Protein kinase inhibition 207 by pentacyclic triterpenes 207Protein synthesis 407 inhibitor of 407Protein transduction domain (PTD) 840, 844Proteolytic activity 841*Protium kleinii* 206 anti-inflammatory effect of 206antinociceptive effect of 207resin of 206use in folk medicine 206Protohypericin 607, 608 structure of 608Protonated astaxanthin 534 delocalisation of 534in crustacyanin 534structure of 534Protonated carotenoids 546 bond lengths of 546dipole moments of 546Protopseudohypericin 607, 608 structure of 608Protozoocidal activity 329, 741, 742 against *Leishmania* 329against *Plasmodium* 329against *Tryponosoma* 329genus *Baccharis* 741*in vitro* 329 of neo-clerodane diterpenoids 742of quinone derivative 329Protozoocidal compounds 740 use of 740Protozoocidal neo-clerodane diterpenoids 741 structure of 741Provitamin D derivatives 489UV irradiation of 489Provitamin 486UV irradiation of 486Provitamin A 520Provitamins A~1~ 520*Prunella vulgaris* 401 antiviral activity of 401Pseudohypericin 608, 627 against cytomegalo virus 627against human immunodeficiency virus-1627against influenza virus 627as virucidal agents 627structure of 608*Pseudomonas aeruginosa* 739 antibacterial activity against 739antifungal activity against 739*Pseudomonas cepacia* lipase 473 in isopropenyl acetate 473Pseudorabies virus 404 *in vitro* replication of 404role of heparin 404Psoriasis 484 use of 1α,25(OH)~2~D~3~ 484Psychiatric disorders 369 anorexia 369bipolar disorder 369bulimia 369effect of circadian activity on 369obsessive compulsive disorder 369panic disorder 369schizophrenia 369seasonal effective disorder 369unipolar depression 369*Psycotria colorata* 205 to relieve abdominal pain 205use in earache 205*Psycotria* species 205 trimmer hodgkinsine from 205Pulmonary vascular injury 70 role of serine protease in 70role of thrombin in 70Punta Toro virus 411 treatment of 411Purification methods 825 affinity chromatography as 825gel filtration as 825high-pressure liquid chromatography (HPLC) as 825ion exchange as 825sulfuric ammonia precipitation as 825Purkinje cells 375, 379, 383 serotonin (5-HT)5A receptor in 375, 379serotonin (5-HT)5A mRNA in 383Putranjivadione 644 stereochemistry of 645NOESY experiment of 645Pyranoses 451--453 syntheses from 451--453Pyridine 562, 567 from genus *Hernandia* 566, 567from *Hernandia* sp. 562(3S,5R,6S,3′R)-Pyrrhoxanthin 517 structure of 517Pyruvate dependent aldolases 423 catabolic function of 423equilibrium of 423*in vivo* 423Pyruvate-dependent aldolases 424 structure of 424Polysaccharide (PS) (MAR-10)396 from *Hyssop officinalis* L. 396Plasma concentration 500 of 1α,25(OH)~2~D~3~ 500of 1α,25(OH)~2~D~4~ 500Polyhydroxylated 2-phenylbenzofurans synthesis 222 from 1,2-diarylethanoid units 222
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QSAR analysis 195 of Δ^8^-tetrahydrocannabinol 195Quercetin 208, 749 analgesic effect of 208from *Phyllanthus* sp 207structure of 749Quinone methides 694 antiplasmodial activity of 694from *Salacia kraussii* 694Quinonemethides 666 biosynthetic pathway of 666Quinones 304, 682 biosynthesis of 682from angiosperms 304from bacteria 304from fungi 304from gymnosperms 304from lichens 304occurrence of 304structural characteristics of 304Quinones sources 341--346 plant cell cultures as 341--346
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Rabdosin 227 structure of 227Rabies virus 409 in humans 409in pets 409target for 409inhibitor of 409Rabies virus infection 409 in chicken-embryo-related cells 409Rabies virus replication 409 in nerve fibers 409Rachitic bone healing potencies 484 of vitamin D~2~ 484of vitamin D~3~ 484of vitamin D~4~ 484of vitamin D~5~ 484of vitamin D~6~ 484of vitamin D~7~ 484Radioligand binding assay 801 of δ opioid receptor 801of δ opioid receptor 801Radioligands 814 from brain membrane synaptosomes 814Radioprotective effect 293 in mice 293Raman spectroscopy 540 principles of 540scope of 540limitations of 540*Rapanea umbellate* 65724-(E)-3-oxo-dammara-20, 24-dien-26-al from 657Raphe nuclei 368 role in attention regulation 368role in cognitive functions 368Raphe nuclei 370 tryptophan hydroxylase (TPH) in 370Rat brain synaptosomes 807δ-affinity in 807Rat mammary carcinogenesis model 592 cancer chemopreventive activity in 591Rat serum vitamin D-binding protein (DBP) 494 binding assay for 494Receptor 421 and cell-cell adhesion 421and cell-cell communication 421antigenic determinants of 421for bacteria 421for viruses 421δ-Receptor 799κ-Receptor 799δ-Receptor 799δ-Receptor affinity 814 binding properties of 814δ-Receptor affinity 814 binding properties of 814of glycopeptide 814δ-Receptor agonists 797 pharmacological activity of 797K-Receptor agonists 797, 806 pharmacological activity of 797δ-Receptor agonists 797 pharmacological activity of 797δ-Receptor antagonists 797 pharmacological activity of 797K-Receptor antagonists 797 pharmacological activity of 797δ-Receptor antagonists 797 pharmacological activity of 797Receptor binding assay 810*in vitro* 810 mouse vas deferens (MVD) activity in 810of guinea-pig ileum (GPI) 810Receptor binding properties 815 of Tyr-D-Ala-Phe-\[β-D-Glc(OAc)~4~\]Tyr-Pro-Ser-NH~2~ 815of Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH~2~ (deltorphin C) 815of Tyr-D-Ala-Phe-Asp-Val-Val-Thr(β-d-Glc)-Gly-NH~2~Tyr-D-Ala-Phe-Thr\[β-D-Glc(OAc)~4~\]-Val-Val-Gly-NH~2~ 815of Tyr-D-Ala-Phe-Asp-Val-Val-Thr\[β-d-GIc(OAc)~4~\]-Gly-NH~2~ 815of Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH~2~ (deltorphin C) 815of Tyr-D-Ala-Phe-Gly-Tyr-Pro-Thr(β-D-Glc)-Gly-NH~2~ 815of Tyr-D-Ala-Phe-Gly-Tyr-Pro-Thr\[β-D-Glc(OAc)~4~\]-Gly-NH~2~ 815of Tyr-D-Ala-Phe-Thr(β-D-Glc)-Tyr-Pro-Ser-NH~2~ 815of Tyr-D-Ala-Phe-Thr(β-D-Glc)-Val-Val-Gly-NH~2~ 815Recombinant prourokinase (pro-UK) 839 as fibrinolytic enzymes 839Recombinant tissue-type plasminogen activator 839 as fibrinolytic enzymes 839Recombinant tissue-type plasminogen activator (rt-PA) 844Red cell 59, 60, 66, 67 effects of carp oil on 66effects oleic acid on 67effects of triterpenoid fractions on 59Redox inhibitors 225 of 5-lipoxygenase 225Reduced nicotinamide adenine dinucleotide (NADH) 384Regelone 643 structure of 643Regeol A 675 acetylation of 675^13^C-NMR data of 675 from *Tripterygium wilfordii* var.*regelii* 675^**1**^ **H**-NMR of 675MS spectrum of 675UV absorption of 675Regeol B 639 from *Tripterygium wilfordii var.regelii* 639Regeol C 675^13^C-NMR data of 675 from *Tripterygium wilfordii* var.*regelii* 675^**1**^ **H**-NMR data of 675NMR spectra of 675Reperfusion injuries 224 role of free radicals in 224Rescorcinolic lipids 165--167 effects on enzymatic activity 165--167interaction with proteins 165--167Resiniferatoxin 193 from *Euphorbia resinifera* 193Resistance-modifiers 595 antimalarial drugs as 595Resistant *Plasmodium* species 595 in chloroquine sensitivity 595Resonance Raman spectra 540 of carotenoid cation radicals 540Resorcinolic lipids 119, 158, 160, 162--164 as antifungal fluids 160as growth reulators 162--163as hair restoration-lotion 160effect on nucleic acid 163--164from *Bacillus subtilis* 158from *Ginkgo biloba (Ginkgoaceae)* 119from *Micrococcus lysodeictius* 158in host-parasite relationship 162--163used in gingival infections 160Resorcinolic lipids interaction 169--172 with bilayer membrane 169--172with biological membrane 169--172with phospholipids 169--172Respiratory depression 799 due to analgesic alkaloid 799Respiratory disorder 224 role of free radicals in 224Respiratory infection 408Respiratory syncytial virus 395Retained placenta 597 treatment of 597use of *Hernandia moerenhoutiana*in 597use *of Hernandia nymphaeifolia* in 597use of *Hernandia yoyronii* in 597(+)-Reticuline 566, 595, 596 antimalarial activity of 595antiplasmodial activity of 596as platelet aggregation inhibitor 594effect on antiplasmodial activity 596from *Hernandia cordigera* 566from *Hernandia guianensis* 566from *Hernandia peltata* 566from *Hernandia* sp. 594from *Hernandia voyronii* 566Retinal 520, 521 in visual signal transduction 520structure of 521Retinoic acid 493, 498, 521 ester of 521in cell differentiation 521in development 521in growth regulation 521structure of 521synthesis of 493*via* nuclear receptors 521Retinol 520 cleavage of 520Retroviral enzymes 397 inhibitor of 397Retroviruses 394, 397, 408 causative agent of immunodeficiency syndrome 394inhibitor of 408Rett\'s disorder (RTT) 372, 373, 384 by mutations in *MECP2* gene 373genetic basis of 373Reverse transcriptase 226, 395, 397 role in HIV replication cycle 226role in viral replication 397Reverse transcriptase PCR (RT-PCR) 827Reverse transcriptase-PCR (PCR) 843Rhamnan sulphate 403 from *Monostroma latissimum* 403*Rheedia gardneriana* 207 antinocicieptive effect of 207*Rheum emodi* T. 327 physcion from 327Rheumatism 192, 691 use of non-steroidal anti-inflammatory drugs (NSAIDs) 192use of prostaglandin inhibitors 192Rheumatoid arteriosclerosis 70Rheumatoid arthritis 70, 204, 225 in rats 204reagent-induced 204treatment of 225use of *Kalopanax pictus* in 203Rhodophin glucoside 521, 522 structure of 522Ricinoleic acid 193 analgesic action of 193*Ricinus communis* 193 ricinoleic acid from 193Rickets 484 role of vitamin D~2~ in 484Rift valley fever infection 411 treatment of 411*Rizophora apiculata* Blume 396*Rizophora mucronata* 396RJ bioassay 807, 814 activity of deltorphin B in 807of glycopeptide 814RNA (nucleoid) 384, 393 energy-generating 394post-transcriptional modifications of 384replication of 394RNA editing 384 at serotonin (5-HT)~2C~ receptor 384RNA virus 394 arenavirus type of 394bunyavirus type of 394coronavirus 394influenza virus 394measles virus 394parainfluenza virus 394picornavirus type of 394rabies virus 394reovirus type of 394rotavirus type of 394RNA-dependent RNA polymerase activity 407 virion-associated 407Roeperanone 621 structure of 621ROESY correlation 586 of (7R,8S,7′R,8′R)-(+)-7′-acetyl-5′-methoxypicropodophyllin 586Rofecoxib 192 as COX-2 inhibitor 192Roridin D 737, 736 structure of 737Roridins 743 antiviral activity of 743Rosaceae 610 acylphloroglucinols from 610Rotavirus gastroenteritis 406 treatment of 406Rotaviruses 406Rubella virus replication 374, 409 autistic features in 374blocking by 409inhibitory effect on 409Rudivirus 409Rutein 523 in human retina 523Rutin 208, 747 analgesic effect of 208structure of 747

S {#cesec190}
=

Sagecoumarin 220 isolation of 220structure of 220*Salacia campestris* 639, 667 cyclase activity of 639*Salacia krausii* 667, 693, 694 against bilharziasis 693against dysentery 69328-hydroxyisoiguesterine from 667 quinone methides from 694*Salacia madagascariensis* 667 isoiguesterine from 667*Salacia oblonga* 645 uses of 645Salicin 195 from *Salix fragilis* 195from *Salix purpurea* 195(2′S)-Salinixanthin 517 structure of 517*Salix fragilis* 195 salicin from 195*Salix purpurea* 195 salicin from 195Salmon nasal cartilage 101 glucose uptake inhibition by 101*Salvia* 242 flavonoids of 242*Salvia blepharophylla* 246 diosmetin from 246pedalitin from 246*Salvia cyanescens* 244 salvigenin from 2456-hydroxy-7,4-dimethoxyapigenin from 245*Salvia officinalis* 219 neolignan from 219*Salvia pinnata* 244 apigenin from 244luteolin from 244*Salvia plebeia* 247 hispidulin 7-glucuronide from 247*Salvia triloba* 243 salvigenin from 243*Salvia uliginosa* 247 petals of 247Salvianolic acids 221 synthesis of 221Salvigenin 726 structure of 726*Sambucus nigra* 407 antiviral activity of 407Sampsoniones 625 structure of 625Sandfly fever **Sicilian** virus (SFSV) 410, 412 phlebovirus type of 410*Saponaria officinalis* 407 antiviral activity of 407Saponification 489, 498 of 3β-acetyl group 498vitamin D analogues by 489Saponin fraction 86 in oolong tea 86SAR 205 of (+)-allomatrine 205of (+)-matrine 205*Sargasm horneri* 400, 405 anti-CMV activity of 405polysaccharide (PS) from 400*Sargasum muticum* 400 polysaccharide (PS) from 400*Sarothra gentianoides* 605 n-nonane from 605Satratoxins 743 antiviral activity of 743Scattering intensity 835 role in assay 835Schizophrenia 368, 369, 379 effect of circadian activity on 369role of serotonin (5-HT) 368Schottenol glucoside 720 structure of 720Schreiber\'s synthesis 6--10 of (+)-discodermolide 6*Sclerotium glucanicum* 401 scleroglucan from 401Scutellarein 288 structure of 288*Scutellaria altissima* 250 baicalein from 250*Scutellaria baicalensis* 55, 56, 69, 254, 289 baicalein from 55flavonoids from 56, 289in allergric inflammatory disease 69viscidulin III from 254*Scutellaria discolor* 251 norwogonin from 251wogonin from 251*Scutellaria ocellata* 248 wogonin from 248*Scutellaria przewalskii* 249 apigenin from 249Scutionin αB 685^13^C-NMR spectra of 6852D NMR spectroscopic data of 685^**1**^ **H**-NMR spectra of 685 molecular formula of 685structure of 685SDZ-249--665201 antinociceptive activity of 201anti-hyperalgesic activity of 201Seasonal affective disorder 369 effect of circadian activity on 369Seaweeds 404 anti-CMV activity of 404Secondary metastatic tumor growth 64 effect of triterpenoids on 64δ-Selective agonist 807 dermorphin 807δ-Selective antagonist 806, 811Tyr-Tic-Phe-NH~2~ 806δ-Selective dipeptides 812 bioactive conformation for 812δ-Selective opioid agonist 817 deltorphin B 817δ-Selective opioid peptide 802δ-Selective opioid peptide 817κ/δ-Selectivity 811 of 6N-cinnamoyl-β-naltrexamine (CNX) 811of ICI 19944811of k opioids 811δ,δ-Selectivity 819*in vivo* 819 of glyco analogues 819Semi-empirical methods (AMI) 542 for calculations 542Sendai virus infection 412Sennosides 305 structure of 305Sensory neurons 194 hyperpolarisation of 194*Sentellaria scandens* 2535,7,2′,5′-tetrahydroxy-6-methoxyflavanone from 253Sephadex LH-20 chromatography 502Sephadex LH-20234 use for flavonoid purification 234Serine 836α~2~-macroglobulin inhibition by 836Serine protease 70, 830, 832, 833, 840 active site of 833amino acid of 833annelid worm from 832binding groups of 833cleavage site of 833EFEa as 840F-I-2 as 840F-II as 840F-I-I as 840 role in blood coagulation 70role in platelet activation 70role in pulmonary vascular injury 70up-and down-stream of 833Serine-like proteases 828Serotonergic fibers 368 distribution of 368Serotonergic innervations 377 autoradiographic imaging 377in cerebral cortex 377in neonatal rats by immunohistochemical techniques 377physiological role of 377Serotonergic neurons 368, 376 in raphe nuclei 376role in regulation of neurogenesis 368Serotonergic neurotransmission 368 abnormalities of 368effect on behavioral dysfunction 368effect on neuronal differentiation 368effect on proliferation 368effect on synaptogenesis 368Serotonin 367, 368, 369, 376, 377, 378, 379, 381, 384, 627 as hyperforin inhibitor 627as neurotransmitter 367degradation of 379, 382depletion of 378early embryonic central nervous system 378effect of monoamine oxidase (MAO) 377effect on synaptogenesis 378from tryptophan 369in apoptosis 367in cell proliferation 367in migration 367in presynaptic neuron 381morphogenic properties of 367neurochemical connection of 368physiological mechanism of 367receptor activity of 379, 382release of 379, 380role in anxiety 368role in austism 368role in behavior 367role in brain processes 367role in depression 368role in fear 376role in human mood 368role in hypertension 368role in irritable bowel syndrome 368role in mental disorders 368role in migraine 368role in obsessive-compulsive disorder 368role in panic disorder 368role in pathological anxiety 376role in schizophrenia 368role in social interaction 368role in social phobia 368synthesis of 379, 380transport of 379, 380Serotonin (5-HT) metabolism 379 role of polymorphism in 379Serotonin (5-HT) precursor 368 tryptophan 368Serotonin (5-HT) receptor genes 382, 383 chromosomal localization of 383Serotonin (5-HT) receptors 376, 378, 382, 383 classes of 382functional aspacts of 378in brain 383in limbic brain regions 383in hippocampus 376molecular aspects of 378pharmacological aspects of 378subtype of 378Serotonin (5-HT) receptor families 382Serotonin (5-HT) re-uptake inhibitors 368 mechanism of 368Serotonin (5-HT) synthesis 370, 376, 377 from tryptophan 370in autistic children 377in denate nucleus 377in frontal cortex 377in thalamus 377role of aromatic L-amino acid decarboxylase (AADC) in 370role of tryptophan hydroxylase (TPH) 370Serotonin (5-HT) transporter-linked polymorphic organ 384Serotonin (5-HT) transporter-linked polymorphic region (5-HTTLPR) 381Serotonin (5-HT)~1A~ 383GPCR superfamily of 383Serotonin (5-HT)1 AR receptor antagonists 378 in postnatal treatment 378Serotonin (5-HT)~1B~ 383GPCR superfamily of 383Serotonin (5-HT)~1D~ 383GPCR superfamily of 383Serotonin (5-HT)~1E~ 383GPCR superfamily of 383Serotonin (5-HT)~1F~ 383GPCR superfamily of 383Serotonin (5-HT)~2A~ 383GPCR superfamily of 383Serotonin (5-**HT)** ~2B~ 383GPCR superfamily of 383Serotonin (5-HT)~2C~ 383GPCR superfamily of 383Serotonin (5-HT)~3~ 383 ligand gate ion channel superfamily of 383Serotonin (5-HT)~4~ 383GPCR superfamily of 383Serotonin (5**-HT)** ~**5a**~ 383GPCR superfamily of 383Serotonin (5-HT)~5A~ mRNA 375, 383 in limbic structures 383in purkinje cells 383Serotonin (5-HT)~5A~ receptor 375 in brain development 375in phenotypic behavioral irregularities 375in purkinje cells 375mRNA expression of 375Serotonin (5-HT)~5B~ 383GPCR superfamily of 383Serotonin (5-HT)~6~ 383GPCR superfamily of 383Serotonin (5-HT)~7~ 383GPCR superfamily of 383Serotonin (5-HT)TLPR 384Serotonin action 378 on apoptosis 378on maturation 378on neuronal functioning 378on proliferation 378Serotonin degrading enzyme 382 monoamine oxidase A (MAOA) as 382Serotonin synthesis inhibitor 378 parachlorophenylalanine as 378Serotonin T (5-HTT) gene 381 polymorphism of 381Serotonin transporter (5-HTT) 380 role in reuptake of serotonin 380Serum transaminases 80Serum triglyceride (TG) 784Sesquiterpene alcohols 715 from *Baccharis dracunculifolia* D. 715Sesquiterpene pyridine-type alkaloids 695Sesquiterpenes 716 from *Baccharis boliviensis* 716Sexually-transmitted disease agents 406 microbicidal compounds against 406sGOT 292activities of 292sGPT 292activities of 292Sharpless asymmetric dihydroxylation (SAD) 463Shikimic pathway 420, 431, 6093-deoxy-D-arabino-2-heptulosonic acid 7-phosphate (DAHP) role in 431Sialic acid derivatives 428 by aldol reaction 428Sialic acids 423 metabolism of 423Side effect 194, 799 of analgesic alkaloid 799of opioids 194*Sideritis marmorea* 260 trimethoxykaempferol 260*Sideritis raeseri* 258 apigenin from 258*Sideritis* species 259 p-coumaroylglucosides from 259Signal reception 377 in autistic children 377Sildenafil 155 used for erectile dysfunction 155Silica gel column chromatography 62 in isolation of triterpenoid fractions 62(S)-3-Silyloxy-2-methylpropanal derivatives 19Simian immunodeficiency virus (SIV) 412Single nucleotide polymorphisms (SNP) 384*Siphocampylus verticillatus* 204 antinociception effect of 204piperidine alkaloid hydrochloride from 204Site-mutation 829 of earthworm species 829β-Sitosterol 570 from *Hernandia guianensis* 570from *Hernandia nymphaeifolia* 570Skin diseases 732Skin inflammation 323 anthrones used for 323Skullcapflavone II 288 structure of 288Smith\'s synthesis 13--19 of (-)-discodermolide 13--19Snake bite 691 treatment of 691use of *Crossopetalum gaumeri* 691Social phobia 368 role of serotonin (5-HT) 368Soft agar transformation assay 592, 593 for isolation of (+)-epiyangambin 593for isolation of (7R,8S,7′R,8′R)-(+)-7′-acetylpicropodophyllin 593for isolation of lignan 593Sonodione 566 from *Hernandia sonora* 566*(+)-Sophora* species 205 sophoranol from 205Sores 616 tricyclic acylphloroglucinols in 616Soybean lipoxygenase-1225 studies on 225Soybean trypsin inhibitor (SBTI) 843, 836Spartidienedione 715 structure of 715Spasmoly activity 264, 561, 748 of *Hernandia moerenhoutiana* 561of *Hernandia voyronii* 561of *Thymus satureioides* 264on guinea pig ileum 748on smooth muscles 264Spathulenol 607, 715, 724 from *Baccharis dracunculifolia* D. 715structure of 724Spectroscopic analysis 591 role in chemopreventive activity 591*Spirulina platensis* 399, 404, 408 anti-influenza activity of 408biological activity of 404calcium spirulan from b399polysaccharide (PS) from 408Spleen / adipose tissue weight 56, 57, 66 effect of fucoidan on 56, 57effect of oleic acid on 65*Stachys chrysantha* 270 xanthomicrol from 270*Stachys* flavonoids 270--272*Staphylococcus aureus* 628, 739 antibacterial activity against 739antibacterial properties of 628antifungal activity against 739*Staphyllococcus aureus* 693 minimal inhibitory concentration (MIC) of 693*Staphyllococcus epidermidis* 693 minimal inhibitory concentration (MIC) of 693*Staphyllococcus saprophyticus* 693 minimal inhibitory concentration (MIC) of 693*Staphyllococcus warnieri* 693 minimal inhibitory concentration (MIC) of 693Stearic acid 65 from carp oil 65*Stenogramme interrupta* 402 carrageenans from 402*Sterculia urens* Roxb. 405 antiviral activity of 405Stereochemistry 502, 584, 586, 587 of (-)-hernone 587of (+)-malekulatine 584of *(7R,8S,7′R,8R)-(+7′-acetyl-*5′-methoxypicropodophyllin 586of vitamin D metabolites 502Stereoisomeric 5,7-diacetamido-3,5,7,9-tetradeoxy-2-nonulosonic acids 434 synthesis of 434Stereoisomers 145 of triene 145Stereospecific α-glycosylation 459Steroid moiety 486, 487 synthesis of 486, 487Steroid moiety synthesis 486 acetylation in 486deoxygenation in 486iodonization in 486LiAlH~4~ reduction in 486 ozonolysis in 486Sterols 562, 569--570 from genus *Hernandia* 563, 569--570from *Hernandia* sp. 562Stigmasta-4, 22-dien-3-one 570 from *Hernandia nymphaeifolia* 570Stigmasterol 208, 505, 570, 719 analgesic effect of 208from *Baccharis linearis* 719from *Baccharis rhomboidalis* J. 719from *Hernandia guianensis* 570Stilbenes 222 oxidation of 222Streptokinase (SK) 839, 844 fibrinolytic enzymes 839*Streptomyces* sp. 26, 29 pironetin from 26*Striga asiatica* 162 infection with 162Structure 64, 197, 202, 369, 485, 571--580 of 1α,25-dihydroxyvitamin D 485of 1α-hydroxyvitamin D analogues 485of 5-hydroxytryptamine 370of 5-hydroxytryptophan 369, 370of 9-nor-9β-OH-hexahydro-cannobinol (HHC) 196of aminoalkylindoles 196of anandamide endocannabinoids 196of cannabinoid receptor ligands 197of capsaicin 202of capsazepine 202of CP-55 940of Δ^9^- tetrahydrocannabinol (THC) 197of diarylpyrazoles 196of ganoderic acid F 63of olvanil 202of tryptophan 369Structure activity relationship studies (SAR) 195, 494, 800 of anandamide 196of aspirin 195of opioid analogues 800of vitamin D analogues 493Structure elucidation 26 of pironetin 26Structure-based inhibitor modeling 832 of (EFEa) 832Substance P 192 as pain mediator 192Sufentanil 200 as morphine analogue 200Sugar derived heptosyl bromide 440 as substrate 440in KDN synthesis 440in Neu5Ac synthesis 440Sugar protons 240 stereochemistry of 240Sulfuric ammonia precipitation 825 enzyme isolation by 825Sulphated polysaccharide (PS) 398, 400, 405 anti-CMV activity of 405anti-HIV activity of 398antiviral activity against HIV 400effect on viral replication 400from marine sources 400inhibitory effect of 398mechanisms of action of 400Sulphated polysaccharide (PS) extracts 399 from brown algae 399from red seaweed 399inhibitory activity of 399Sulphur trioxide/pyridine complex 527 chlorosulphinic acid from 527pyridine from 527Suppressing activity 308 on cells proliferation 308Suppurative dermatitis 88 use of *Platycodon grandiflorum* in 88Surrogate 471 reductive ozonolysis of 471Suzuki coupling reaction 19, 22Swern oxidation 20, 30, 45, 462 of primary alcohol 45Sympathetic ganglia 782 blockade of 782Sympathetic nerve activity 787Synaptic actions 381 of serotonin 381Synaptogenesis 368, 377 effect of serotonergic neurotransmission on 368role in rodents 377role of serotonin in 377Synergistic effect 498, 596 of hervelines B 596of hervelines C 596of retinoids 498of vitamin D derivatives 498Synergistic purgative actions 306 of rheinanthrone 306of aloe-emodin-anthrone 306Synthesis 485--494, 370, 504, 608*in vitro* 608 of 24-epi-D~2~ 490of 24-epi-D~6~ 490of natural steroids 504of retinoic acid 493of serotonin 370of steroid moiety 486of vitamin D analogues 485--494of vitamin D derivatives 491of vitamin D~2~ 490of vitamin D~3~ 490, 493of vitamin D~4~ 490of vitamin D~5~ 490of vitamin D~7~ 490Synthetic pharmacological agents 224 antioxidant activity of 224γδ-T-cells 766, 768 in CVE-administered mice 768in protection after listerial infection 766
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*Thymbra spicata* 272 luteolin from 272Tail flick test 802, 810 for determination of antinociception 802of deltorphin II 810of DTAOH+DEL II 810of DTOH+DEL II 810Takai reaction 38, 41*Tanacetum parthenium* 206 in treatment of migraine 206Target genes 496 transcription of 496Taxol 5 as microtubule stabilizing agent 5Taxol-resistant breast 5 clinical development for 5chemotherapeutic agent for 5Taxol-resistant colon cell 5Taxol-resistant ovarian cell 5Taxonomic characterization 561 of genus *Hernandia* 561Tea 80 effect on lipids (total cholesterol triglyceride) 80Tea saponin 84, 86 effect on pancreatic lipase activity 86effect on parametrial adipose weight 85effect on triacylglycerol contents 84in feces 84Terpenoids (classified) 706 diterpenes (C~20~)706monoterpenes (C~10~)706sesquiterpenes (C~15~)706triterpenes and steroid (C~30~)7062, 37,8-Tetrachlorodibenzofuran (T~4~CDF) 763 excretion of 763Δ^8^-Tetrahydrocannabinol 195 computational molecular modelling of 195pharmacological potency of 195QSAR analysis of 195Δ^9^-Tetrahydrocannabinol 195 as natural analgesic product 195structure of 197type of classical cannabionoid 197Tetrahydrocannabinol 196 molecular field analysis of 196Δ^6^-Tetrahydrocannabinol (THC) 194 as analgesic 194in mediterranean fever 194in migraine 194pharmacological properties of 195pharmacological studies of 1945,6, 13, 14-Tetrahydroxy-1,2,9, 10-tetrahydro-1,9-epoxydibenzo\[a,e\] cyclooctene 227role in HIV-1 IN inhibitor activity 227Tetrahydroxypavinan 225 effect on 5-lipoxygenase inhibition 22519, 19′,20, 20′-Tetranor-β-carotene 550 structure of 550*Teucrium arduini* 255 cirsimaritin 4′-glucoside from 255*Teucrium* flavonoids 255Th2 cells 773 differentiation of 773in antibody production 773in humoral immunity 773Th2-type immune response 778 inhibition by IFNγ778Thalamocortical connection 377 development of 377Thalamus 193, 377 serotonin synthesis in 377(+)-Thalicarpine 567, 595 as platelet aggregation inhibitor 594from *Hernandia nymphaeifolia* 567from *Hernandia ovigera* 567from *Hernandia peltata* 567from *Hernandia* sp. 594(+)-Thalicarpine-2′-N-oxide 567 from *Hernandia peltata* 567Thalifoline 566, 590 activity in human cancer cell line 589activity in murine cancer cell line 589cytotoxic effect of 589from *Hernandia nymphaeifolia* 566(+)-Thalmelatine 567 from *Hernandia peltata* 567Δ^9^-THC classical cannabinoid 197 cannabinoid receptors ligands 197Thebaine 193 from *Papaver somniferum* 193Therapeutic agents 396 for AIDS 396Therapeutic application 399 of sulphated polysaccharide (PS) 399Therapy 393 for bacterial infection 393for fungal infection 393for parasitic infection 393for viral infection 393Thermal isomerization 486, 489 of provitamin D derivatives 486, 489of vitamin D analogues 489Thermal model of nociception 205 analgesic effect in 205α-Thioanomers 5 effect on cell proliferation 5β-Thioanomers 5 effect on cell proliferation 5Thombin-stimulated ELAM-170Thrombin 70, 594, 838 platelet aggregation induction by 594role in blood coagulation 70role in platelet activation 70role in pulmonary vascular injury 70Thrombin fibrin clots 154 generation of 154Thrombin receptor 70 cleavage of 70Thrombin receptor agonist peptide 69, 70 in cultured HUVECs 69Thrombin-fibrinogen solution 835Thrombin-induced adhesion 55 inhibited by baicalein 55Thrombin-stimulated ELAM-1 70, 71 inhibitory effect on 70, 71Thrombin time assay 403Thrombocystosis 839 treatment of 839Thrombolytic agent 839 adverse effect of 839bleeding complications due to 839recombinant prourokinase (pro-UK) as 839recombinant tissue-type plasminogen activator as 839re-occlusion due to 839staphylokinase as 839streptokinase (SK) 839Thromboplastin time assay 403Thrombosis 55, 839, 840 role of natural products in 55treatment of 839, 840*Thymus piperella* 263 luteolin 7-glucoside from 263TIC insertion 806 on dynorphin 806(Tic^2^) dermorphin 809 activity in functional bioassay 809(Tic^2^, Leu^5^) enkephalin 809 activity in functional bioassay 809\[Tic^2^\] deltorphin C 807, 818 activity in MVD bioassay 807, 818agonist activity *in vitro* 818Time-resolved resonance Raman spectroscopy 540Tin-assisted tosylation reaction 463Tingenone 665, 668 from *Euonymus tingens* 668structure of 665Tissue plasminogen activator (t-PA) 830, 844TLR2 777, 778, 781, 782 from gram-positive bacteria 778in ARS-2 mediated cellular activation 781in cellular reponses 782Tobacco mosaic virus infection 412 against yeast mannans 412α-Tocopherolquinones 304 as primary metabolites 304Togaviruses 394, 409Togavirus infection 409 in pregnant women 409vaccination against 409Tolerance 194, 799 due to analgesic alkaloid 799due to opioids 194Toll-like receptors 777Tonic 64 carp as 64Tonsillitis 88 use of *Platycodon grandiflorum* in 88Toothache 203 use of ginseng root in 203Tormentic 207 antinocicieptive effect of 207Total plasma cholesterol 95 effect of chitin-chitosan on 95Tournefolal acid 223 structure of 223Toxic chemical 762 dioxin as 762polychlorinated biphenyl (PCB) as 762Tragacanthin polysaccharide (PS) 411 effect on liver 411effect on liver infection scores 411effect on mortality 411effect on serum transaminase 411effect on spleen virus titer 411from *Astragalus brachycentrus* 411from *Astragalus echidnaeformis* 411Tranquillizing activity 200 of droperidol 200Transcriptional activity 496, 497 of 1α,25(OH)~2~D analogue 497Transplantable Meth A tumor 776Transplanted murine tumor cell lines P 388 pironetin against 27TRAP-induced ELAM-1 expression inhibition of 70Treatment 597 of postpartum hemorrhage 597of malaria 597of morning sickness 597*Trichilia glabra* 411 anti-polio virus activity of 411Trichothecene complex 751 of antibiotics 751Trichothecenes 751 fungal toxins 751phytotoxicity of 751role in mycotoxicoses 751role in plant pathogenicity 751toxicity toward eucaryotic organisms 751Trienone 486 enolacetylation of 486from ergosterol 4862-\[bis(2,2,2-Trifluoroethoxy)phosphorylJ-1,3-dithiane 459Trifluoromethyl pharmacophore 228 as HIV-1 IN inhibitor 2282,3, 22β-Trihydroxy-24--29-dinor-1,3,5(10),7-friedelatetraene-6, 21-dione-23-al 679^13^C-NMR experiment of 679HREIMS of 679IR absorption of 679 molecular formula of 679ROESY experiment of 679 structure of 6792,3, 22 β-Trihydroxy-24--29-dinor-25 (9→8)-1,3,5(10),7-friedelatetraene-21-one-23-al 680 ^13^C-NMR of 679^**1**^ **H**-NMR spectrum of 679HMBC of 679HMQC experiment of 679molecular formula of 679Trimethylsilylated compound 239NMR spectrum of 239Triphenyl phenol scutigeral 193 analgesic action of 193*Tripterygium doianum* 6543β-acetoxy-11-ursen-13α,30-olide from 654*Tripterygium hypoglaucum* 646, 654 hypodiol from 646triptohypol Dfrom 654*Tripterygium wilfordii* 639, 641, 648, 664, 676, 689, 6902α,3β-dyhdroxy-olean-12-ene-22, 29-lactone from 6482β,22β-dihydroxy-3, 21-dioxo-24-carboxyl-29-nor-friedelan methyl ester from 6416α-hydroxytriptocalline-A from 641 as anti-AIDS agent 639as anticancer 639as insecticide 639as traditional medicine 689celastrol from 664for rheumatoid arthritis treatment 689for spondylitis treatment 689in treatment of rheumatoid arthritis 639in treatment of spondylitis 639inhibitory effects of 690pristimerin from 664triptocallic acid D from 648wilforic acid A from 676*Tripterygium wilfordii var. regelii* 639, 642 regelone from 642regeol B from 639Triptocallic acid A 653^13^C**-NMR** of 653^**1**^ **H** NMR of 6532D NMR of 653FAB-MS NMR of 653 from *Tripterygium wilfordii* 653IR NMR of 653 structure of 653Triptocallic acid B 652 structure of 652Triptocallic acid C 652^13^C-NMR data of 652El-mass fragmentation pattern of 652 from *Tripterygium wilfordii* 652molecular formula of 652Triptocallic acid D 648^13^C-NMR spectrum of 648FAB-MS spectrum of 648 from *Tripterygium wilfordii* 648^1^H-^13^C COSY spectra of 648^**1**^ **H**-NMR spectroscopic data of 648NOESY experiment of 648 stereochemistry of 648structure of 648Triptocalline A 640, 641^13^C-NMR spectrum of 641 from *Tripterygium wilfordii* 640structure of 641Triptohypol A 677^13^C-NMR experiment of 677 from *Tripterygium hypoglaucum* 677^**1**^ **H**-NMR spectrum of 677NOESY experiment of 677Triptohypol B 677^13^C-NMR spectrum of 677Triptohypol C 678^13^C-NMR data of 678 molecular formula of 678structure elucidation of 678UV absorption of 678Triptohypol D 654, 655^13^C-NMR spectral data of 654^**1**^ **H**-NMR data of 6542D-NMR spectral data of 654 from *Tripterygium hypoglaucum* 654HMBC of 656 molecular formula of 654NOESY spectrum of 654, 656 structure of 655Triscutin A 687^13^C-NMR spectra of 687^**1**^ **H**-NMR spectra of 6872D NMR spectroscopic data of 687 molecular formula of 687structure of 687Triscutin B 688^13^C-NMR spectra of 6882D NMR experiments of 688FAB-MS of 688^**1**^ **H**-NMR spectrum of 688 molecular formula of 688structure of 688Triterpenes 637--663 biological activities of 637physiological function of 637chemistry of 637--663Triterpenoid fractions 59, 60, 62 activity in matrigel-implanted angiogenesis assay 62effects on hemoglobin 59, 60effects on leukocytes 59, 60effects on red cell 59, 60isolation of 62of *Ganoderma lucidum* 60use of silica gel column chromatography 62Triterpenoids 55, 56, 58, 59, 61, 64 antimetastatic effects of 58antitumor activity of 58effect on angiogenesis 61effect on DNA synthesis 61effect on liver metastasis 55effect on primary solid-tumor growth 64effect on secondary metastatic tumor growth 64effect on tumor cell colonies 59effect on tumor growth 55from *Ganoderma lucidum* 56Tropical diseases 329 malaria as 329TRPM8193 type of ionotropic receptor 193use in cold-allodynia 193TRPVI 193 activation of 193receptor desensitisation of 193role in neuropeptide release 193role in nociceptor excitation 193TRPVI (VRI) activation 193 by acidosis 193by lipid mediators 193by noxious heat 193TRPVI expression 206 effect of capsaicin on 206effect of Polygodial on 206TRPVI receptor blockade 203 by ginsenosides 203Trypanocidal effect 741 of Paraguayan compositae 741Trypomastigotes 331*in vitro* 331 of *Trypanosoma cruzi* 331Trypsin 831, 830, 837Arg-X cleavage site of 837 homologous sequences of 831Lys-X cleavage site of 837Trypsin production 204 inhibition by hederagenin monodesmosides 204Tryptohypol F 647, 648^13^C-NMR spectrum of 648^**1**^ **H**-NMR of 648MS spectra of 648NOESY spectrum of 648 stereochemistry of 648structure of 647Tryptophan 369 in mammalian systems 369role in light receptor molecules 369structure of 369Tryptophan decarboxylase activity 371 in brain neurons 371in non-nervous tissue cells 371Tryptophan hydroxylase 369, 384, 370 in brain stem 370in raphe nuclei 370role in serotonin (5-HT) synthesis 369, 370Tryptophan hydroxylase (TPH) activity 370 in beta-cells 370in intestinal cells 370in mast cells 370in mononuclear leukocytes 370in pancreatic enterochromaffin cells 370mechanism of 370Tuberous sclerosis 374 autistic features in 374Tumor 61 in LLC-bearing mice 61Tumor cell colonies 59 role of triterpenoid fractions 59Tumor growth 56, 57, 60, 64, 70 efect of fucoidan on 56effect of triterpenoid fractions on 60in sarcoma 56in spleen 64inhibited by carp oil 64inhibited by oleic acid 64prevention of 60Tumor metastasis 55 role of natural products in 55Tumor prevention 64 use of carp oil 64Tumor production inhibition 695Tumor promoter 592TPA as 592Tumorigenesis 316 initiation of 316promotion of 316Tumor-promotion agents 592 diterpene esters from 59212-O-tetradecanoylphorbol 13-acetate(TPA) 592Two-stage mouse skin model 591 cancer chemopreventive activity in 591Tyr-(Me)~2~-D-Phe-Gly-Val-Val-NH~2~ 812, 813 activity in GPI assay 812binding bioactivity of 813functional bioactivity of 813Tyr-(Me)~2~-D-Phe-NH~2~ 812, 813 activity in GPI assay 812binding bioactivity of 813functional bioactivity of 813Tyr(Me)~2~-Phe-NH~2~ 813 binding bioactivity of 813functional bioactivity of 813Tyr-(Me)~2~-Phe-NHCH~3~ 812 energy map of 812\[Tyr)Me)~2~-Phe\] peptides 813 binding bioactivity of 813functional bioactivity of 813Tyr-D-Ala-Phe-\[β-D-Glc(OAc)~4~\]Tyr-Pro-Ser-NH~2~ 815 receptor binding properties of 815Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH,(deltorphin C) 815 receptor binding properties of 815Tyr-D-Ala-Phe-Asp-Val-Val-Thr(β-d-Glc)-Gly-NH~2~Tyr-D-Ala-Phe-Thr\[β-D-Glc(OAc)~4~\]-Val-Val-Gly-NH~2~ 815 receptor binding properties of 815Tyr-D-Ala-Phe-Asp-Val-Val-Thr\[β-d-Glc(OAc)~4~\]-Gly-NH~2~ 815 receptor binding properties of 815Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH~2~(deltorphin C) 815 receptor binding properties of 815Tyr-D-Ala-Phe-Gly-Tyr-Pro-Thr(β-D-Glc)-Gly-NH~2~ 815 receptor binding properties of 815Tyr-D-Ala-Phe-Gly-Tyr-Pro-Thr\[β-D-Glc(OAc)~4~\]-Gly-NH~2~ 815 receptor binding properties of 815Tyr-D-Ala-Phe-Thr(β-D-Glc)-Tyr-Pro-Ser-NH~2~ 815 receptor binding properties of 815Tyr-D-Ala-Phe-Thr(β-D-Glc)-Val-Val-Gly-NH~2~ 815 receptor binding properties of 815Tyr-Tic-NH~2~ 809 activity in functional bioassay 809Tyr-Tic-Phe-NH~2~ 806 as δ selective antagonist 806
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